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I investigated strategies for reducing Varroa mite populations (Varroa destructor)
in honey bee colonies (Apis mellifera) using oxalic acid (OA). I examined the efficacy of
OA in both broodless colonies and colonies that contain brood. My data indicate that OA
is most effective at reducing Varroa populations when colonies are broodless because
repeated applications of OA did not significantly reduce mite populations in colonies
when brood was present. Next, I quantified the contact toxicity of OA to Varroa mites
and their honey bee hosts in laboratory bioassays. The results indicate that OA has a low
acute toxicity to honey bees and a high acute toxicity to mites. The toxicity data will help
guide scientists in delivering lethal dosages of OA to the parasite and in protecting its
host.
I also investigated how OA is distributed in honey bee colonies when applied
using the trickle method. For this study, I constructed nine divided Langstroth hives
using 3 different types of dividers that allowed trophallaxis, physical contact, or
fumigation. I treated bees on one side of the divider and then monitored mite mortality
on both the treated and untreated sides. Bee-to-bee contact was the primary route for OA
distribution. Finally, I developed a protocol for using OA to eliminate mites from
package bees. I made 97 packages of Varroa-infested adult bees. I sprayed an OA
solution directly on the bees through the mesh screen of the package cages using a
pressurized air brush. I quantified mite and bee mortality and estimated the optimum
dosage of OA to apply to package bees for mite control without injuring bees. The
application of 3 mL of a 2.8% OA sugar water solution per 1000 bees will allow
beekeepers to safely reduce populations of Varroa mites from packages prior to

installation. My research is significant because it offers beekeepers a safe, effective, and
sustainable method for reducing Varroa populations.
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Introduction

Varroa jacobsoni was first described by Oudemans in 1904 as a natural
ectoparasitic mite of the Eastern honey bee, Apis cerana F. Recently, Anderson and
Trueman (2000) reported that V. jacobsoni is a complex of 2 different species that
parasitize A. cerana. The original species, V. jacobsoni, encompasses 9 haplotypes that
infest A. cerana in the Malaysia-Indonesia region. In contrast, the newly described
species, Varroa destructor, includes 6 haplotypes that infest A. cerana on mainland Asia.
Adult females of V. destructor are larger and less spherical than females of V. jacobsoni,
and the 2 species are reproductively isolated (Anderson and Trueman 2002).
Movement of the European honey bee, Apis mellifera L. into areas where A.
cerana is endemic let V. destructor transfer to A. mellifera, a far less resistant host (De
Jong et al. 1982). V. destructor found on A. cerana in Asia exhibit commensalism, a
host-parasite relationship that is advantageous to V. destructor but does not negatively
affect A. cerana (Büchler 1994, Boecking et al. 1998). In contrast, A. mellifera colonies
infested with V. destructor usually die in 3-5 years without beekeeper intervention (De
Jong et al. 1982).
Since the discovery of V. destructor (Varroa) in the United States in 1987
(Anonymous 1987), the feral population of honey bees has dramatically declined (Kraus
and Page 1995, Harbo and Hoopingarner 1997). Managed honey bee colonies have also
been severely injured (Sammataro 1997, Martin 2001). Furthermore, Varroa has added
considerable labor and expense to the cost of managing honey bees (Ellis 2001, Sanford
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2001). Varroa is generally considered the most severe threat to beekeeping worldwide
(De Jong 1990, Beetsma 1994, Martin 1998, Anderson & Trueman 2000).
Currently, 8 chemical treatments are registered in the United States to control
Varroa mites: 1) Apistan® (fluvalinate), 2) CheckMite+® (coumaphos), 3) Mite-Away
II® (formic acid), 4) Apicure® (formic acid), 5) Apiguard® (thymol), 6) ApiLife-Var®
(blend of thymol, eucalyptol, menthol, and camphor), 7) Sucrocide® (sucrose octanoate),
and 8) Hivastan® (fenpyroximate). Apistan® has been used extensively for Varroa
control, achieving nearly 100% efficacy in susceptible mite populations (Faucon et al.
1995). Apistan® is sold in plastic strips impregnated with fluvalinate that are suspended
between frames in the brood chamber for 6-8 weeks. They require contact with the
cluster of bees to be effective. Apistan® was first registered in Nebraska in 1990 and
reports of resistant mite populations emerged between 1996 and 1997 (Creger 2007).
Fluvalinate resistance has been widely reported in the United States (Eischen 1995, 1998,
Elzen et al. 1998, 1999, Macedo et al. 2002a,) and Europe (Milani 1994, Lodesani et al.
1995, Thompson et al. 2002). Today, many beekeepers have discontinued the use of
Apistan® because its effectiveness has significantly decreased.
The prevalence of fluvalinate-resistant Varroa mite populations in the late 1990’s
led many U.S. beekeepers to begin using CheckMite+®, an organophosphate acaricide,
as an alternative mite control agent. Like Apistan®, CheckMite+® is sold as plastic
strips impregnated with a miticide (coumaphos) that are placed in the brood chamber for
6 weeks. Efficacy of 97-99% has been documented (10% coumaphos strips) (Milani and
Iob 1998). CheckMite+® was first registered in Nebraska in 1999 and reports of
resistant mite populations emerged between 2002 and 2003 (Creger 2007). By 2002,
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several instances of coumaphos resistance were reported in the United States (Elzen and
Westervelt 2002, Pettis 2004).
Mite-Away II® is a ready-to-use, single application formic acid pad that is
effective at controlling both Acarapis woodi (tracheal mites) and Varroa mites. The pad
is made from wooden fibers and contains 292 grams of 65% formic acid. The treatment
period is 21 days and the outside daytime temperature should be between 50 and 79°F.
Significant adult bee and brood mortality may occur if the daytime temperature exceeds
82°F during the treatment period. Several other formulations of formic acid have been
shown to be effective but are not registered or available to beekeepers. Calderone (2000)
was able to achieve 94% efficacy when treating colonies with 300 mL of 65% formic
acid in a slow release evaporator, but effective and reliable control has proven elusive.
Liquid formic acid can also be used to reduce Varroa populations.
Apicure® is formic acid in a gel-like base that slowly releases the active
ingredient. Apicure® is sealed in plastic bags that are sliced open and placed in the hive
for 3 weeks. Apicure® has limited use due to problems with packaging that prevent mail
services from accepting it for shipment. For this reason, Mite-Away II® is the preferred
Varroa product for those wishing to use formic acid.
Apiguard® is thymol in a slow-release gel matrix. Thymol is a naturally
occurring substance derived from various species of thyme plants (genus Thymus).
Thymol has proven efficacy against Varroa mites, tracheal mites, and chalkbrood.
Apiguard® can be purchased in ready-to-use aluminum trays containing 50 g of thymol
or purchased in 1 or 3 kg tubs. Fifty grams of Apiguard® is placed on top bars of the
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brood chamber and a second 50 g treatment is applied after the first treatment has
evaporated (2-4 weeks). The total treatment period is 4-6 weeks.
ApiLife-Var® is composed of a vermiculite tablet (5 x 9 x 1 cm) impregnated
with a 20 gram mixture of thymol (76%), eucalyptol (16.4%), menthol (3.8%), and
camphor (3.8%). Three tablets are placed on the top bars of brood combs and are left in
place for 4-8 weeks. Imdorf et al. (1995) reported that 95% mite mortality was achieved
if temperatures were optimal (between 15 and 21°C). ApiLife-Var® is most consistently
effective when applied to hives that are contained in a single brood chamber. In contrast,
its efficacy is less consistent when treating multiple story colonies. Imdorf et al. (1994,
1995) found that mite mortality varied considerably when treating multiple story
colonies.
Sucrocide® is 40% sucrose octanoate. The label recommends spraying the bees
clustered on each frame at 7-10 day intervals. Three treatments are recommended. Few
data indicating the efficacy of Sucrocide® are available. However, Sheppard et al.
(2003) reported that following a single treatment with sucrose octanoate esters (solution
of 0.3% active ingredient in water; 1.5 ounces per frame), mite mortality ranged from
38% to 87%.
Hivastan® is a contact miticide that contains 0.3% fenpyroximate. The product is
a thick, pliable formulation that can be formed into patties. The label recommends
applying a 225 g patty of Hivastan® on the top of the brood frames on paper, wax paper,
or cardboard. Two 225 g treatments per year per colony are permitted. Adult bees
consume the patties, and in the process, get the material on their bodies and transfer it to
other bees in the colony by physical contact. In typical circumstances, the initial 225 g
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application will be consumed or removed in 6 weeks. The Hivastan® label precautions
that a slightly higher incidence of adult bee mortality can occur during the initial 48-72
hours of the treatment period compared with untreated colonies.
Chemical resistance, the variable efficacies of current Varroa treatments, the
adverse effects of treatments on bees, and the risk of hive and hive product contamination
create a need for alternative treatment methods. Oxalic acid (OA) is extensively used for
controlling V. destructor in Europe and Canada due to its high efficacy (>90%) and low
risk of hive contamination (Charrière & Imdorf 2002, Special Supplement 2005). Its
registration is pending in the United States. OA is applied to colonies by spraying or
trickling a solution of OA in a 1:1 sugar water solution over the bees (Charrière & Imdorf
2002) or by sublimating crystals with heat. When spraying or trickling OA in Canada,
the recommended application per hive is 50 mL of a solution containing 35 g OA
dihydrate in one L of 1:1 sugar:water (w:v). When spraying or trickling OA, the
maximum dose is 50 mL per hive, whether the bees are in nucs, single, or multiple brood
chambers. When evaporating OA in Canada (vaporizer method), the recommended
application is 1 g OA dihydrate per hive body (Langstroth hive body, 24.4 cm depth)
(Special Supplement 2005). Although OA provides effective control of V. destructor, its
mode of action is unknown. Further, only one study has quantified the contact toxicity of
OA to V. destructor (Milani 2001), and the contact toxicity of OA to honey bees has not
been determined. In short, OA is extensively used without knowing the basic
toxicological properties of the compound to V. destructor or A. mellifera.
There are many important research opportunities surrounding OA. My
dissertation research focuses on evaluating OA for reducing Varroa mite populations in

6
honey bee colonies and package bees, determining factors that influence efficacy, and
investigating the mode of distribution of OA. The results from my research have
important implications for the development and implementation of effective management
strategies for controlling Varroa mites. Specifically, objectives for my work are:
1. To evaluate strategies for reducing Varroa mite populations using OA in
both broodless and brood rearing colonies.
2. To quantify the contact toxicity of OA to Varroa mites and their honey bee
host in laboratory bioassays.
3. To investigate factors that contribute to the distribution of OA in a hive.
4. To develop a protocol for using OA to reduce Varroa mite populations in
package bees.
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Literature Review

History of Varroa in the United States
Varroa destructor was first found in the United States in 1987 in Wisconsin
(Anonymous 1987). Since their introduction, Varroa mites have spread rapidly across
the United States. Varroa are spread locally by drifting of infested adult worker and
drone adult bees, by the movement of swarms, and by bees robbing weakened colonies
(De Jong 1990). Movement of infested colonies for wintering and crop pollination and
the shipment of package bees and queens are probably responsible for the rapid dispersal
of Varroa in the United States (de Guzman 1993). Varroa has greatly reduced
populations of feral bee colonies in many parts of the United States (Kraus and Page
1995, Harbo and Hoopingarner 1997). Substantial losses of managed honey bee colonies
have also been attributed to Varroa injury (Beetsma 1994, Sammataro 1997, Martin
2001, Sanford 2001).
The number of honey bee colonies in the United States has declined steadily since
1947. In 1947, the number of colonies peaked at 5.9 million (Hoff and Willett 1994). By
2006, the number of colonies had dwindled to 2.4 million (USDA 2007). Some of the
decline may be attributed to urban growth and a reduction in forage plants due to
monocultural farming practices and herbicides (NASS 1993). Recently, price
competition from imports and the deleterious effects from the spread of both tracheal
mites (Acarapis woodi) and Varroa mites have accelerated the drop in the number of
managed colonies (NASS 1993). Varroa is considered the most severe threat to
beekeeping worldwide (De Jong 1990, Beetsma 1994).
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Lately, colony collapse disorder (CCD) has afflicted an estimated 23% of
beekeeping operations across the United States (Cox-Foster et al. 2007). CCD has
resulted in a loss of 50 to 90% of colonies in affected beekeeping operations over the
winter of 2006-2007 (Cox-Foster et al. 2007). CCD is characterized by the inexplicable
loss of a colony’s adult bee population and few or no dead bees in or around the hive.
The later stages of CCD are typified by colonies that have 5 or more frames of brood,
honey reserves and a queen, but that lack sufficient adult bees to cover and care for the
brood. The few bees that remain are frequently newly emerged bees. Although the cause
of CCD has not been definitively proven, a team of scientists led by Diana Cox-Foster
have found that Israeli acute paralysis virus of bees (IAPV) is strongly correlated with
CCD (Cox-Foster et al. 2007). While the Cox-Foster et al. (2007) paper presents
convincing evidence that CCD is related to the presence of IAPV, many questions about
CCD remain unanswered. It is unknown whether IAPV acts alone or in concert with
other factors such as Varroa mites, poor nutrition, exposure to pesticides, and climate.
Other viruses associated with Varroa infestation include acute paralysis virus, Kashmir
bee virus, and deformed wing virus (Sammataro 1997). Their contribution to the CCD
problem and interaction with IAPV are under investigation (Cox-Foster et al. 2007).

Varroa biology
Adult female V. destructor are large (1.1 X 1.6 mm), reddish brown, dorsalventrally flattened external parasites of all castes of honey bees (De Jong 1990, Fries
1993). Adult female Varroa are phoretic on adult bees and are found principally on the
underside of the abdomen between the overlapping abdominal sternites. Varroa feed on
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haemolymph by piercing the intersegmental membranes with their chelicerae (De Jong
1990). Varroa only leave adult bees to enter brood cells where they reproduce and mate.
Mites invade worker and drone cells 15-20 hours and 40-50 hours preceding cell capping,
respectively (Boot et al. 1992). Drone larvae are preferred over workers, and drone
brood is often 8-10 times more infested than worker brood (Fuchs 1990).
To begin its reproductive phase, an adult female mite must be carried to a suitable
brood cell by a bee. The mite then transfers from the adult bee to the rim of the cell and
quickly moves inside quickly (Boot et al. 1994). After entering the cell, the mite
immediately buries itself underneath the bee larva and enters the larval food. At this
time, the mite assumes a characteristic position with its posterior ventral plates facing the
opening of the cell. The anterior dorsum, mouthparts, anterior ventral plates, and the
bases of its legs are submerged in the larval food. The peritremes protrude out of the
semi-liquid food, perpendicular to its surface (De Jong 1984). The mite remains in this
position up to 4 hours after cell capping or until the larval food is consumed. Once
liberated from the brood food by the feeding larva, the mite commences feeding on larval
haemolymph (De Jong 1984).
Approximately 60 hours after the cell is capped, the female mite lays a single,
male egg. Subsequent female eggs are laid at intervals of 30 hours. Female mites can lay
a maximum of 6 female eggs in a drone cell and 5 female eggs in a worker cell (Ifantidis
1983). The immature mites develop inside the egg. At this time, a 6-legged larva is
visible within. Approximately 1.5 days after the deposition of a female egg, an 8-legged
protonymph hatches. This stage lasts about 3 days, allowing the female mite to feed,
grow, and then molt to an 8-legged deutonymph. The deutonymphal stage (similar in
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size and shape to the adult female) also lasts about 3 days. Both protonymphal and
deutonymphal stages are subdivided into a mobile and immobile stage. About 7.5-8 days
after the egg is laid, the female deutonymph molts into an adult (Ifantidis 1983, De Jong
1984, 1990).
The male mite develops from egg to adult in 5.5-6 days and is smaller, paler, and
less sclereotized than the female. The adult male’s chelicerae (mouthparts used for
piercing the bee’s integument by the female) are modified for sperm transfer, rendering it
unable to feed. Mating takes place within the cell, and adult female mites leave with the
emerging adult bees. The males and immature females that are present when the adult
bee emerges perish (Ifantidis 1983, De Jong 1984, 1990). Studies of egg chromosome
number have revealed that the first egg laid normally develops into a male and the
subsequent eggs into females (Rehm and Ritter 1989). Varroa have a haplodiploid
system of sex determination (arrhenotoky). Males arise from unfertilized eggs and have
7 chromosomes. In contrast, females arise from fertilized eggs and have 14
chromosomes (Ruijter and Pappas 1983).
There is a strong preference for mite reproduction in drone brood when both
worker and drone brood are available (Boot et al. 1992, De Jong 1984, Fuchs 1990). The
mechanisms governing this preference are not completely understood and are frequently
debated. Le Conte et al. (1989) suggest that chemical stimuli may be important, as
simple aliphatic esters isolated from drones attract mites. Boot et al. (1992) propose that
the larger number of mites found in drone cells may be partly due to the longer period of
mite invasion into drone brood. Physical differences between drone and worker cells
may also influence mite distribution in brood cells. De Jong and Morse (1988) found that
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raised cells (drone cells) are more attractive to mites than normal worker cells. Finally,
drone brood is capped about 2 days longer than worker brood. The adaptive advantage of
reproducing in drone brood is clear considering a greater number of mites are able reach
sexual maturity and mate due to the longer developmental period (21 days for workers
and 24 days for drones).
An important aspect of Varroa biology is disease transmission. Varroa destructor
feeds on the haemolymph of larvae, prepupae, pupae, and adult honey bees. The
female’s piercing chelicerae effectively function as “dirty syringes,” exposing its host to
many pathogens, including viral, bacterial, microsporidial, and fungal diseases (Ball
1994). Adult bee symptoms of Varroa infestation include a reduction in population,
deformed wings, bees crawling away from the hive that are unable to fly, and queen
supercedure. Brood symptoms include a spotty brood pattern and brood that appear
discolored and abnormally positioned. Symptoms may resemble European foulbrood,
American foulbrood, or sacbrood disease (Hung et al. 1995). Shimanuki et al. (1994)
proposed the name “parasitic mite syndrome” (PMS) for these symptoms. Several
viruses may be associated with PMS, but their role in PMS has not been established. The
most commonly observed viruses associated with Varroa infestation include sacbrood
virus (SBV), acute bee paralysis virus (ABPV), chronic bee paralysis virus (CBPV),
Kashmir bee virus (KBV), deformed wing virus (DWV), black queen cell virus (BQCV),
and Israeli acute paralysis virus (IAPV) (Sammataro 1997, Cox-Foster et al. 2007).
There is evidence that Varroa do not cause honey bee colonies to expire solely from
feeding. They also act indirectly by activating viruses and providing a port of entry for
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bacterial and fungal diseases. Diseases may play a role that is equal or greater than mite
feeding injury in colony death (Hung et al. 1995).

Varroa on Apis cerana vs. Apis mellifera
Varroa jacobsoni was first described by Oudemans in 1904 as a natural
ectoparasitic mite of the Eastern honey bee Apis cerana F. Peng et al. (1987) discovered
that A. cerana has evolved both physiological and behavioral adaptations to V. jacobsoni
parasitism. Apis cerana worker bees are able to detect Varroa as they respond
immediately to mite introduction. The presence of Varroa triggers a series of behavioral
responses including auto-grooming, dancing to solicit nest mate grooming, nest mate
cleaning, and group cleaning. Eventually, these behaviors lead to the removal of many
mites from the adult bees and brood (Peng et al. 1987, Harris 2007).
Recently, Anderson and Trueman (2000) reported that V. jacobsoni is a complex
of 2 different species that parasitize A. cerana. The original species, V. jacobsoni,
encompasses 9 haplotypes that infest A. cerana in the Malaysia-Indonesia region. In
contrast, the newly described species, Varroa destructor, includes 6 haplotypes that infest
A. cerana on mainland Asia. Movement of A. mellifera by humans into areas where A.
cerana is endemic in the 1950’s enabled V. destructor to transfer to A. mellifera, a far
less resistant host (De Jong et al. 1982). De Jong et al. (1982) reported that colonies
parasitized by Varroa began dying in autumn of the first year of infestation. Frequently,
all colonies in an apiary died in 3-5 years. Peng et al. (1987) discovered that grooming
behavior occurs less frequently in Varroa-infested A. mellifera colonies, and that few
mites are removed by grooming. Additionally, A. mellifera brood has a longer
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developmental period (21 days for workers and 24 days for drones) than A. cerana,
allowing Varroa to reproduce in both worker and drone brood. In contrast, Varroa mites
parasitizing A. cerana reproduce almost exclusively in drone brood (developmental time
of 22 days) because the developmental time of A. cerana worker brood (18 days) is
insufficient for mite reproduction (Boot et al. 1997).
Adult female Varroa mites from different honey bee species show high
phenotypic consistency, except for body size. Female mites infesting A. cerana are
generally smaller than those infesting A. mellifera. Delfinado-Baker (1988) reported that
the behavioral, physical, and physiological differences exhibited by Varroa on A. cerana
and A. mellifera suggest that V. jacobsoni may be more than one species. Twelve years
later, Anderson and Trueman (2000) were able to clearly demonstrate (through a
comprehensive comparative study based on molecular techniques) that V. jacobsoni is
actually 2 species: V. destructor and V. jacobsoni. It is now clear that both V. jacobsoni
and V. destructor parasitize A. cerana, and that only V. destructor parasitizes A.
mellifera.

Detection methods and treatment thresholds
It is essential to assess the degree of V. destructor infestation in honey bee
colonies to prevent colony injury or loss. Accurate estimation of mite population allows
beekeepers to employ control measures when warranted and to save time and money
when treatment can be delayed (Macedo and Ellis 2000). Commonly used detection
methods for Varroa include ether roll, sugar roll, alcohol wash, brood examination, sticky
boards placed on the bottom board, and acaricides with sticky boards. Detailed
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descriptions of these methods can be found in USDA Agricultural Handbook Number
690, Diagnosis of Honey Bee Diseases (Shimanuki and Knox 2000).
Regardless of the detection method employed, assessing the degree of Varroa
infestation is crucial in determining if control measures are warranted. In the Midwest,
colonies with more than 0.12 mites-per-bee when brood is not present (in the fall) will
have increased winter mortality if mite populations are not reduced. Colonies with more
than 0.25 mites-per-bee will almost always perish in the winter (Ali and Ellis 2000).
When brood is present in mid-August, 0.03 or more mites-per-bee indicates that the
beekeeper should implement treatment measures as soon as possible. This may require
sacrificing honey production to conserve the colonies (Macedo and Ellis 2001).
Although the above treatment thresholds are a good indicator for Varroa treatment in the
Midwest, Delaplane (1998) noted that treatment thresholds can vary regionally.
Delaplane and Hood (1997) suggested that late-season acaricide treatments in first-year
colonies in the southeastern United States are justified when 300-bee ether roll levels are
15.1 ± 1.4 mites. Variation in the duration of the brood rearing period affects mite
population dynamics, and may explain why treatment thresholds have not been
established for most of the United States (Delaplane and Hood 1997). The lack of
treatment thresholds for all regions and the time required to determine Varroa infestation
result in many beekeepers applying annual or semi-annual prophylactic miticide
treatments (Strange and Sheppard 2001).
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Varroa control

Chemical control
Currently, 6 general use (Section 3) chemical treatments are used to control V.
destructor in the United States: Apistan® (fluvalinate), Apicure® (formic acid), MiteAway II® (formic acid), Sucrocide® (sucrose octanoate), Apiguard® (thymol), and
ApiLife-Var® (76% thymol, 16.4% eucalyptol, 3.8% menthol, and 3.8% camphor). The
first product registered for Varroa control in the United States was Apistan®. It achieved
nearly 100% efficacy in susceptible mite populations (Faucon et al. 1995). Fluvalinate’s
target is the axonal transmission of nerve impulses. It alters the permeability of sodium
channels and causes prolonged depolarization of nerve membranes. Apistan® was
initially approved in 1990 as a Section 3 general use chemical, and its Section 3
registration remains active in the United States (U.S. EPA 2007a). However, the active
ingredient, tau fluvalinate, was available to beekeepers under a Section 18 registration
from 1987-1989. Liquid formulations of fluvalinate were applied to wooden strips that
were placed in the brood chamber (Ellis et al. 1988). Currently, Apistan® is sold as
impregnated plastic strips that are placed in the brood chamber for 6-8 weeks and act as a
contact pesticide. Fluvalinate resistance has been documented in the United States
(Eischen 1995, 1998, Elzen et al. 1998, 1999, Macedo et al. 2002a,) and Europe (Milani
1994, Lodesani et al. 1995, Thompson et al. 2002). Efficacy has been reported to drop to
10-70% in mite populations that have developed resistance (Pettis et al. 1998, Macedo et
al. 2002a). Today, many U.S. beekeepers have discontinued the use of Apistan® due to
loss of efficacy.
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Apicure® is 65% formic acid in a gel-like base that slowly releases the active
ingredient. Apicure® is sealed in plastic bags that are sliced open and placed in hives for
3 weeks. Formic acid is a fumigant that kills Varroa by respiratory inhibition (Imdorf et
al. 1999. Since fumigant volatilization is temperature dependent, the results of treatment
often exhibit variable results. Queen loss and brood damage are common side effects of
overexposure to formic acid. Several other formulations of formic acid have been shown
to be effective but are not registered or available to beekeepers. Calderone (2000) was
able to achieve 94% efficacy when treating colonies with 300 mL of 65% formic acid in a
slow release evaporator, but effective and reliable control has proven elusive. Although
registered (Section 3), Apicure® is not available to most beekeepers due to packaging
problems and the refusal of mail services to accept the current packaging for shipment.
To date, Apicure® has not been widely distributed or applied. Mite-Away II® is the only
formic acid based miticide currently available to U.S. beekeepers.
Mite-Away II® has a Section 3 registration that was approved on March 31, 2005
(U.S. EPA 2005). Mite-Away II™ is a ready-to-use, single application formic acid pad
that is effective at controlling both tracheal and Varroa mites (Mite-Away II® U.S.
label). The pad is made from wooden fibers and contains 292 grams of 65% formic acid.
A 3.8 cm spacer rim must be placed over the brood chamber to accommodate the MiteAway II® pad. The pad is placed in the hive directly over the brood chamber. The
treatment period is 21 days and the outside daytime temperature should be between 50
and 79°F. The label recommends that applicators remove the pads from hives in the
event of a heat wave (>82°F) within the first 7 days of treatment. Significant adult bee
mortality, brood mortality, and absconding may occur if the daytime temperature exceeds
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82°F during the treatment period. Like Apicure®, the formic acid present in Mite-Away
II® acts as a fumigant and kills Varroa by respiratory inhibition (Imdorf et al. 1999),
rendering its effectiveness highly variable. Formic acid is also hazardous to applicators
and the EPA mandates stringent precautionary labeling for Mite-Away II®.
Sucrocide® (40% sucrose octanoate) is a general use Varroa treatment and is
classified as a biopesticide by the EPA. Sucrose octanoate is a mixture of sugar esters
that are manufactured from sucrose (table sugar) and an octanoic acid ester that is
commonly found in plants and animals. The label recommends spraying both sides of
each frame at 7-10 day intervals. Three treatments are recommended. The surfactant
effect of sucrose octanoate esters de-waxes the cuticle of Varroa, causing desiccation
(U.S. EPA. 2006a). No harmful effects to bees, humans, or the environment are expected
from the use of Sucrocide® (U.S. EPA 2006a). Few data indicating the efficacy of
Sucrocide® are available. However, Sheppard et al. (2003) reported that following a
single treatment with sucrose octanoate esters (solution of 0.3% active ingredient in
water; 1.5 ounces per frame), mite mortality ranged from 38% to 87%. Currently,
Sucrocide® is available in all states and has a Section 3 registration (U.S. EPA 2006a).
Apiguard® received EPA approval for use in the United States in January 2006.
Prior to United States approval, Apiguard® was only available in European countries.
Currently, Apiguard® has a Section 3 registration in the United States (U.S. EPA 2006b).
Apiguard® is thymol in a slow-release gel matrix. Thymol is a naturally occurring
substance derived from various species of thyme plants (genus Thymus). Thymol has
proven efficacy against Varroa mites, tracheal mites, and chalkbrood (Apiguard® U.S.
label). Apiguard® can be purchased in ready-to-use aluminum trays containing 50 g of

18
thymol in a gel matrix or purchased in 1 kg or 3 kg tubs for beekeepers with many
colonies to treat. The gel is placed in the hive using the dosing tools (scoop and spatula)
that are supplied with the 1 kg and 3 kg tubs. The first dose requires the applicator to
measure 50 g of the gel using the scoop and spatula. To do so, the applicator must
completely fill the scoop with gel and then level the excess with the spatula. The gel is
then spread to an even thickness on a waxy cardboard tray (supplied) and placed centrally
on top of the brood frames. After 2 weeks, a second 50 g dose is applied using the
methods described above. Apiguard® is left in the colony until it disappears completely
from the tray or until supers are installed. Generally, the total treatment period lasts 4-6
weeks.
Registration was initially approved for ApiLife-Var® in 2003 under an EPA
Section 18 Emergency Exemption for states requesting approval due to Apistan® and
CheckMite+® resistance. Currently, ApiLife-Var® has a Section 3 registration in the
United States. ApiLife-Var® is composed of a vermiculite tablet (5 x 9 x 1 cm)
impregnated with a 20 gram mixture of thymol (76%), eucalyptol (16.4%), menthol
(3.8%), and camphor (3.8%). The active ingredient, thymol, is a fumigant that
effectively kills Varroa mites, but its mode of action is unknown. The tablets are placed
on the top bars of brood combs and are left in place for 4-8 weeks. Imdorf et al. (1995)
reported that 95% mite mortality was achieved if temperatures were optimal (between 15
and 21°C). ApiLife-Var® residues in hive products are not considered a health risk. The
applicator should not get ApiLife-Var® on their hand and should not touch their eyes
while treating. ApiLife-Var® is most consistently effective when applied to hives that
are contained in a single brood chamber. In contrast, its efficacy is less consistent when
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treating multiple story colonies. Imdorf et al. (1994, 1995) found that mite mortality
varied considerably when treating multiple story colonies.
Two restricted use products are available for Varroa control in the United States,
CheckMite+® (coumaphos) and Hivastan® (fenpyroximate). Registration was initially
approved for CheckMite+® in 1998 under an EPA Section 18 Emergency Exemption for
states requesting approval due to Apistan® resistance. The EPA has continued to renew
the exemption and has made CheckMite+® available in a number of states on a year-toyear basis. The active ingredient, coumaphos, is an organophosphate and acts as an
acetylcholinesterase inhibitor. This mode of action makes the use of coumaphos
hazardous to applicators. Treatments must be applied at a time when bees are not
producing a surplus honey crop. CheckMite+® is sold as plastic strips impregnated with
miticide that are placed in the brood chamber for 6 weeks. Efficacy of 97-99% has been
documented (10% coumaphos strips) (Milani and Iob 1998). There are also concerns
about the risk of contaminating hive products, and a 4 week withdrawal period is required
before adding surplus honey supers. Chemical resistant gloves must be worn when
handling the strips. Coumaphos is highly lipophilic and residues are most likely to be
found in beeswax. Coumaphos resistance has been reported in the United States (Elzen
and Westervelt 2002, Pettis 2004) and Italy (Lodesani 1996).
Registration was approved for Hivastan® (fenpyroximate) in May 2007 under an
EPA Section 18 Emergency Exemption (U.S. EPA 2007b). Fenpyroximate is a synthetic
acaricide that inhibits the mitochondrial electron transport of complex I (NADH
dehydrogenase) (Nauen and Bretschneider 2002). Hivastan® is a contact miticide that
contains 0.3% fenpyroximate. The product is a thick, pliable formulation that can be
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formed into patties. The label recommends applying a 225 g patty of Hivastan® on top
of the brood frames on paper, wax paper, or cardboard. Two 225 g treatments per year
per colony are permitted. Adult bees consume the patties, and in the process, get the
material on their bodies and transfer it to other bees in the colony by physical contact
(Hivastan® U.S. label). In typical circumstances, the initial 225 g application will be
consumed or removed in 6 weeks. The Hivastan® label precautions that a slightly higher
incidence of adult bee mortality can occur during the initial 48-72 hours of the treatment
period compared with untreated colonies.

Biotechnical control
Chemical resistance, the variable efficacies of current Varroa treatments, the
adverse effects of treatments on bees, and the risk of hive and hive product contamination
create a need for alternative treatment methods. Lindberg et al. (2000) and Ali et al.
(2002) recently evaluated several essential oils and related compounds including clove
oil, benzyl acetate, thymol, carvacrol, methyl salicylate, and perillyl acetate as treatments
for Varroa. The results indicated that the compounds they tested may not be highly
effective under all conditions, but suggest that they could be a useful component of an
integrated pest management approach. Charrière and Imdorf (2002) evaluated oxalic and
lactic acids in Europe as an alternative Varroa treatment. Their results indicate that
oxalic acid is effective in broodless colonies, but their protocol requires applying the
material to the bees on each frame, and bees were harmed if overdosed. Oxalic and lactic
acids can be applied by spraying or trickling on adult bees or by sublimation of the acid
crystals in the hive.

21
Heat treatment (Tabor and Ambrose 2001), powdered sugar dusting (Aliano and
Ellis 2005a, Fakhimzadeh 2000), pollen traps (Cakmak et al. 2002), and even electrical
“zapping” (Huang 2001) have also been evaluated as Varroa treatment methods. Like
other alternative Varroa treatments, the above methods exhibit potential as part of an
integrated pest management strategy, but they are labor intensive and often less effective
than other registered Varroa control products. If labor costs are considered, the
treatments described above are more expensive than the alternatives.
One of the first products used to control Varroa was Sineacar, a mixture of
powdered sugar (98.2%) and chloropropylate and bromopropylate (1.8%) (Ramirez
1994). The “clogging” of the ambulacrum with dust may explain why Sineacar knocked
mites off adult honey bees without killing them first. The ambulacrum of adult female
Varroa is a pretarsus with protractile, claw-like sclerites used for grasping the hairs of
bees (Ramirez and Malavasi 1991). The claw-like sclerites of the ambulacrum enable
mites to move rapidly on adult bees and other substrata. Macedo et al. (2002b) were able
to achieve 92.9 ± 5.5% Varroa mite recovery by isolating bees from their nest and
dusting them with powdered sugar. Similarly, Shah and Shah (1988) reported that a fine
powder of wheat flour was effective at knocking Varroa off adult honey bees, but they
did not indicate the percentage mite fall. In addition to dust adhering to the tarsal pads of
Varroa, Macedo and Ellis (2001) suggest 2 more factors that may contribute to mite fall
when bees are dusted with powdered sugar. They observed that dust stimulates the bees’
grooming behavior and they proposed that it would result in greater mite removal. They
also proposed that dust on the mite’s body may stimulate it to release from its host to
groom itself.
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Fakhimzadeh (2000) evaluated powdered sugar as a tool for Varroa control.
Fakhimzadeh applied sugar directly to adult bees in their nest and counted daily mite fall
following treatment. He found post-treatment daily mite fall was significantly higher
than pre-treatment daily mite fall. However, he did not determine the percentage of mites
that were removed from the hives. Fakhimzadeh concluded that powdered sugar is useful
in reducing mite infestation in a colony, but he indicates that his method still needs
refining. In a related study, Fakhimzadeh (2001b) investigated the effects of powdered
sugar on honey bee colony development. He applied sugar to the colony (10-20g) at 3-,
7-, and 14-day intervals. He observed that sugar particles did not enter the bee’s spiracles
or tracheal ducts. Also, the treatment had no obvious side effects on capped brood or the
growth of the bee population. Additionally, Fakhimzadeh found that powdered sugar
treatment did not cause queen loss or queen supercedure, even if the treatment was
applied as frequently as every 3 days for one month.
Aliano and Ellis (2005a) developed a powdered sugar dusting technique that
requires isolating a colony’s adult bee population in a detachable box prior to powdered
sugar application. By applying a bee repellent to a colony, Aliano and Ellis (2005a)
forced adult bees into a detachable ‘bee box’ where the adult bee population was dusted
with powdered sugar. Adult honey bee populations treated in this manner dropped 76.7 ±
3.6% of their mites. One drawback of the Aliano and Ellis (2005a) technique is that it is
labor intensive and time consuming. Part-time beekeepers are more likely to adopt this
technique than full-time beekeepers, especially those trying to reduce the use of chemical
treatments. Aliano and Ellis (2005b) performed a follow up study to test the effects of
powdered sugar entering brood cells when powdered sugar is applied to a hive. Their
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results indicate that only large amounts (0.6 g per 152 cells) of powdered sugar applied
directly to brood cells harms immature honey bees. Further, Aliano and Ellis (2005b)
indicate that brood removal following management practices that introduce powdered
sugar into colonies will be restricted to eggs.

Genetic control
Another approach to Varroa control is bee breeding. Spivak and Reuter (2001)
reported that colonies bred for hygienic behavior maintained lower mite loads for up to
one year without treatment. Ibrahim and Spivak (2005) showed that bees bred for
suppression of mite reproduction (SMR) also express hygienic behavior. Harbo and
Harris (2001) reported that single drone inseminated queens bred for SMR can
significantly reduce mite populations. Recently, Harris (2007) discovered that honey
bees bred for SMR resist the growth of Varroa mites by removing mite-infested pupae
from capped brood. Harris (2007) named this behavior Varroa-sensitive hygiene (VSH)
and describes VSH as “a multi-step process that involves detection, uncapping of the cell,
and removal of the host.”
Other heritable traits that have been associated with Varroa resistance include the
duration of the capped period and the proportion of mites in brood cells (Harbo and
Harris 1999). A disadvantage of intense selection for one trait is that selection for other
valuable traits (honey production, gentleness, swarming, etc) may be reduced.
Furthermore, intense selection for a single trait may narrow the genetic base over time.
Finally, specific traits such as hygienic behavior and suppression of mite reproduction
may be lost when a colony swarms or supercedes its queen. Resistant stock would lower
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operating costs, reduce selection pressure for mite resistance to chemical treatments, and
reduce the risks of chemical residues in honey and hive products. Varroa resistant lines
probably will not eliminate the need for chemical treatments, but they may help
beekeepers reduce the frequency of treatments and the selective pressures that promote
miticide resistance (Ellis 2001).

Oxalic acid
Oxalic acid (OA) is a dicarboxylic acid and is approximately 10,000 times
stronger than acetic acid. Oxalic acid is available in two formulations: anhydrous
(C2H2O4) (CAS # 144-62-7) and dihydrate (C2H2O4 2H2O) (CAS # 6153-56-6). Oxalic
acid is commonly utilized in the industrial sector as a wood bleaching agent, as a mordant
in dyeing processes, and as a surface pretreatment for stainless steels prior to applying a
corrosion-inhibiting coating. Oxalic acid is also employed in the domestic sector as a
household cleaner and rust remover. A structural sketch of anhydrous OA (C2H2O4) is
included below.
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Oxalic acid is a common chemical in plants, but its physiological role is not
completely understood. Scientists suggest that OA is involved in storage and regulation
of calcium, seed germination, detoxification, ion balance, structural integrity, and insect
repellence (EMEA 2004). Oxalic acid concentrations in plants range from 5 mg/kg up to
20,000 mg/kg dry weight (EMEA 2004). In humans, 30-70% (20-30 mg) of the OA
excreted daily in urine originates from endogenous sources. The daily intake of OA in
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the European diet averages 50 mg per day and is excreted in fecal material (Libert and
Franceschi 1987, EMEA 2004). Dietary intake of OA varies widely based on the types
of food eaten. Although most humans safely consume and excrete OA on a daily basis,
excessive consumption of foods with high OA concentrations is a health concern because
it has been implicated in several clinical disorders including cardiovascular disease and
renal calculi (Singh et al. 1972).
The usefulness of OA as a Varroa mite control agent has been known since the
end of the 20th century (Popov et al. 1989). The commercial availability and the low risk
of hive product contamination render OA an attractive chemical for Varroa control.
Numerous investigations of OA as a Varroa control agent have been conducted in
European countries (Rademacher and Harz 2006). The European Agency for the
Evaluation of Medicinal Products (EMEA) determined the maximum residue limit
(MRL) for OA in honey to be 50 milliequivalents of free acid in December 2004
(Rademacher and Imdorf 2004). In all European countries, government approval is only
given to a veterinary drug after the EMEA has determined the MRL of the active
ingredient. Currently, every European country can apply for the legal approval of OA as
a drug for honey bee colonies because the EMEA has determined the MRL for OA. If
OA is applied properly, there is little risk of harmful residues in honey.
Oxalic acid is also a legal Varroa treatment in Canada. In 2005, Health Canada’s
Pest Management Regulatory Agency (PMRA) made an interim determination that OA
can be safely applied to honey bee colonies to control Varroa provided that specific
limitations and precautions are respected (Special supplement 2005). The Canadian
Honey Council has provided the American Beekeeping Federation (ABF) their
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registration data packet to expedite the registration of OA in the United States. The ABF
is leading the registration process and is working with the United States Environmental
Protection Agency to register OA as a biopesticide. Oxalic acid’s registration is pending
in the United States. My studies will contribute to the registration of OA and will guide
beekeepers in how to apply the product safely and effectively once it is registered in the
United States.
A review article by Rademacher and Harz (2006) summarizes over 50 references
related to the use of OA in European countries. Their review article covers the efficacy
of OA against Varroa and honey bee tolerance for the trickling, spraying, and
evaporating application methods. The trickle and spray methods of OA application were
employed in my dissertation research. I chose to exclude the evaporation method due to
inherent hazards to the applicator. When OA sublimates, both OA and formic acid fumes
are liberated and can permanently damage lung tissues if inhaled. Furthermore, the
European literature regarding OA efficacy indicates that the trickle, spray, and
evaporation methods of application are equally effective against Varroa mites.

Trickling method
The trickling method for applying OA is simple, quick, inexpensive, and
effective. To trickle OA, a solution of OA in sugar water is applied with a syringe
directly onto adult bees occupying the spaces between the combs. It takes about 1.5
minutes to treat a colony and costs 4-5 cents per hive to purchase the OA required.
Rademacher and Harz’s (2006) review found that most researchers recommend a dose of
5 mL per bee space (30-50 mL per hive). Oxalic acid is most effective during autumn or
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when colonies are broodless and the temperature is above freezing. Oxalic acid is most
effective when colonies have little or no brood because OA does not kill mites in sealed
brood cells (Schuster and Schürzinger 2003).
Most research reviewed by Nanetti et al. (2003) and Rademacher and Harz (2006)
found that a single autumn trickle treatment with a 3.0% OA sugar water solution (1:1 by
weight) provided an efficacy of greater than 90% in Central Europe. Charrière and
Imdorf (2002) found that a slightly more concentrated OA solution (3.5%) resulted in
greater than 95% efficacy. They also tested the efficacy of a 3.0% OA sugar water
solution with a lower sugar content (1:2; sugar:water by weight) and concluded that the
solution with a 1:2 ratio of sugar:water seemed to have a negative influence of efficacy,
although the difference was not significant.
Experiments in which OA solutions stronger than 3.5% were applied indicate that
increasing the OA concentration above 3.5% does not increase efficacy (Charrière and
Imdorf 2002, Nanetti et al. 2003). The most concentrated OA solutions examined ranged
between 6 and 8% and reduced the efficacy when compared to a 3 or 3.5% solution
(Liebig 1998, Nanetti et al. 2003). In Central Europe, adult bees tolerated a single
autumn trickle treatment concentration up to 4.6% OA (Büchler 2002, Charrière and
Imdorf 2002, Nanetti et al. 2003). Liebig (1998) quantified the impact on colonies when
applying OA solutions with concentrations greater than 5% and described significant
adult bee mortality, poor over-wintering ability, and impaired spring development.
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Spraying method
Like the trickle method, the spray method is most effective when colonies are
broodless, and it should only be conducted when the temperature is above freezing.
When implementing the spray method, a solution of OA and sugar water is sprayed onto
the adult bees on both sides of each comb. The combs must be individually removed
from their hive bodies for application and adult bees located on the hive walls and bottom
board are sprayed as well. As a result, the spray method requires more time and labor
than the trickle method.
Most studies of the spray method were conducted in Central Europe using
broodless colonies with outside temperatures ranging from 5 to 12.3°C (Rademacher and
Harz 2006). A single autumn spray treatment using a 3.0% OA sugar water solution (1:1
by weight) and doses of 3-4 mL per comb side provided efficacies of 97.3 to 98.8%
(Charrière et al. 2004, Imdorf et al. 1995). These doses were tolerated well as none of
the experimental colonies lost their queen and adult bee mortality was not significantly
increased. However, Charrière et al. (2004) reported winter losses of 11 to 26% of adult
bees. The adult bee losses were numerically higher than control colonies (12 to 16%),
however the differences were not significant.

Other aspects of OA for Varroa control
Although OA provides effective control of Varroa, its mode of action is
unknown. Furthermore, only one study has quantified the contact toxicity of OA to
Varroa (Milani 2001), and the contact toxicity of OA to honey bees has not been
determined. Milani (2001) quantified the toxicity of OA to Varroa mites collected from
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bee brood. Milani reported that the 24 hour LD50 (95% CL) (median lethal density) for
Varroa mites collected from brood was 1.9 (1.49 to 2.36) μg/cm2. One limitation of the
Milani (2001) study is that it did not quantify the toxicity of OA to phoretic Varroa
mites, the life cycle stage that is exposed to OA when colonies are treated (Schuster and
Schürzinger 2003). Interestingly, OA is extensively used without knowing its basic
toxicological properties to either Varroa mites or honey bees.
Recently, Fries (2006) answered an important question regarding OA application
techniques. The question was: which factor is critical for efficacy in Varroa control, the
total amount or the concentration of OA? Fries (2006) divided 89 honey bee colonies
into 3 experimental groups: trickle 30 mL sugar water solution, trickle 30 mL 3.2% OA
sugar water solution, and trickle 60 mL 1.6% OA sugar water solution. The results
showed that trickling 30 mL of a 3.2% OA solution is significantly more effective (92.2%
efficacious) than trickling 60 mL of a 1.6% OA solution (68.3% efficacious). Fries
(2006) clearly demonstrated that it is the concentration of OA that is critical for high
efficacy rather than the total amount of OA applied to a colony.
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Research objectives

My overall dissertation objective was to develop techniques for using OA to
suppress Varroa mites in the North Central Region (NCR) of the United States. When I
started my Ph.D. research in 2004, OA treatment had not been tested in the United States
as a Varroa suppression technique. Chapter 1 describes how I quantified the acute
contact toxicity of OA to Varroa mites and their honey bee hosts in laboratory bioassays.
Chapters 2 and 3 describe how I investigated the efficacy of OA in the NCR of the
United States. Chapters 4 and 5 document my development of a protocol for using OA to
eliminate mites from package bees. Finally, chapter 6 describes my methodology for
investigating how OA is distributed in honey bee colonies when applied using the trickle
method.
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Chapter 1

Acute contact toxicity of oxalic acid to Varroa destructor
(Acari: Varroidae) and their Apis mellifera (Hymenoptera: Apidae) hosts in
laboratory bioassays

Abstract
I performed laboratory bioassays to characterize the acute contact toxicity of
oxalic acid (OA) to Varroa destructor (Anderson & Trueman) and their honey bee hosts
(Apis mellifera). Specifically, I conducted glass-vial residual bioassays to determine the
lethal concentration of OA for Varroa, and I conducted topical applications of OA in
acetone to determine the lethal dose for honey bees. The results indicate that OA has a
low acute toxicity to honey bees and a high acute toxicity to mites. The toxicity data will
help guide scientists in delivering optimum dosages of OA to the parasite and its host,
and will be useful in making treatment recommendations. The data will also establish a
baseline for OA susceptibility for both parasite and host to compare with future
populations if Varroa mites exhibit resistance to OA.

Introduction
The objective of this study was to characterize the acute contact toxicity of OA to
Varroa mites and their honey bee hosts in laboratory bioassays. Only one study has
quantified the contact toxicity of OA to Varroa mites collected from brood cells (Milani
2001), and the contact toxicity of OA to honey bees has not been determined. One
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limitation of the Milani (2001) study is that it did not quantify the toxicity of OA to
phoretic Varroa mites. Oxalic acid does not kill mites in sealed brood cells (Schuster and
Schürzinger 2003), thus the characterization of the contact toxicity of OA to phoretic
Varroa mites has not been determined. Oxalic acid is extensively used without knowing
the basic toxicological properties of the compound to Varroa mites or honey bees. The
results of this research will be useful in formulating treatment recommendations for the
North Central Region of the United States. The data will also establish a baseline for OA
susceptibility for both parasite and host to compare with future populations if Varroa
mites exhibit resistance to OA.

Materials and Methods
Collection of V. destructor
I collected adult worker bees from a single, mite-infested colony of Carniolan
honey bees located on the University of Nebraska campus in February 2005. I shook the
bees from each frame (12 frames total) through a funnel into a bulk bee box. I then
subdivided the bees into six smaller wooden boxes that measured 17.75 cm long, 15.25
cm wide, and 10.15 cm deep (inside diameter). Each box had an 8-mesh screen on one of
the 17.75 cm X 15.25 cm sides for ventilation and mite collection. I attached a pint jar of
sugar water (1:1 by volume) to each box and stored the boxes at 15.6°C in complete
darkness until needed for experimentation (no longer than 2 days).
I harvested mites from adult bees by applying 18 g of powdered sugar through the
screen of each box (Aliano & Ellis 2005a). I inverted the boxes after bees were
thoroughly coated with powdered sugar to collect mites (about 30 s). The boxes
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remained inverted until mite fall ceased (about 20 min). Approximately 100 viable mites
were recovered per cage. I gently brushed the powdered sugar off mites with a fine paint
brush before transferring them to 20 mL glass scintillation vials (Wheaton Scientific,
Millville, NJ) for OA exposure.

Glass-vial residual bioassays for V. destructor
I used techniques described by Plapp and Vinson (1977) and Macedo et al.
(2002a) for conducting glass-vial residual bioassays. I prepared serial dilutions of oxalic
acid dihydrate (>99% purity) (The Science Company, Denver, CO) (CAS # 6153-56-6) in
acetone and conducted a preliminary range-finding bioassay to determine at least 3
concentrations that provided Varroa mortalities >0 and <100%. I prepared 7
concentrations of OA in acetone for the definitive bioassay (1.0, 0.3, 0.1, 0.03, 0.01,
0.003, and 0.001 mg/mL). I pipetted one-half mL of each solution into four, 20 mL glass
scintillation vials for each treatment, including an acetone control. The 8 resulting OA
concentrations that I tested in the definitive bioassay were 500, 150, 50, 15, 5, 1.5, 0.5,
and 0.0 μg OA per vial. I rolled all vials (32 total) on their sides under a fume hood to
evaporate the acetone while evenly coating the vials with OA. I promptly removed the
vials after the acetone had evaporated (4 to 5 min). I gently brushed ten mites into each
vial, screwed the cap on tightly, and placed the vials in a dark incubator for 24 h (26°C
and 90% relative humidity). One vial of 10 mites constituted a replication and four vials
(40 mites) were used for each of the 8 concentrations. I scored mite mortality 24 h later
by examining mites under a light microscope. Mites were considered dead if they did not
respond to probing with a small paint brush.
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Topical application of OA to adult bees
I prepared serial dilutions of oxalic acid dihydrate (>99% purity) (The Science
Company, Denver, CO) (CAS # 6153-56-6) in acetone and conducted a preliminary
range-finding bioassay to determine at least 3 doses that provided honey bee mortalities
>0 and <100%. Two to 7 day old bees from C.F. Koehnen & Sons Inc. (Glenn, CA) were
shipped to the University of Nebraska in March 2005 and were used for the range-finding
bioassay. I used the results from the range-finding bioassay to establish the definitive
bioassay dosage levels.
I conducted the definitive bioassay in September 2005 using 2 to 7 day old bees
that were obtained from brood frames kept in an incubator. I placed 10 bees in each of
32 Benton mailing cages with queen candy. One cage of 10 worker bees constituted a
replication and 4 cages (40 bees) were tested for each treatment. I randomly assigned
each cage to 1 of the 8 concentrations, and all 10 bees within a cage received the same
treatment. I prepared a 200 mg/mL solution of OA in acetone. I dosed honey bees with
10.0, 8.0, 4.0, 2.0, 1.0, or 0.5 μL of the 200 mg/mL stock solution. These doses
correspond to 2000, 1600, 800, 400, 200, and 100 μg OA per bee, respectively. I applied
the doses to individual bee abdomens using a Hamilton microsyringe and repeating
dispenser (Hamilton Company, Reno, NV) after anesthetizing bees with CO2. I included
a 10 μL control (acetone only) in the bioassay along with a dry control in which bees
were anesthetized with CO2 but were not treated with acetone. I held the bees at 21.7 ±
0.4°C and 46.3 ± 1.5% relative humidity in darkness for 72 h except for brief periods
when water was administered to the cages. I provided water twice daily to the bees
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throughout the experiment by brushing the cage screens with several drops of water. I
evaluated mortality 24, 48, and 72 h after treatment.

Statistical analysis
I analyzed the results with Probit analysis (Finney 1971) using the POLO-PC
statistical software (LeOra Software 1991), and I took into account natural mortality.
The concentrations that I used for the Probit analysis of the mite bioassay data were
expressed as μg per vial. The doses that I used for the Probit analysis of the honey bee
bioassay data were expressed as μg per bee.

Results
V. destructor bioassays
The results for the definitive bioassay are summarized in Table 1.1. The natural
mortality for the definitive bioassay was 9.7 ± 3.4% after 24 h.

Honey bee bioassays
Doses of OA less than 100 μg per bee did not cause significant mortality after 48
h in the range-finding bioassay. Further, it was impossible to calculate the 24 and 48 h
LD50’s for honey bees tested in the range-finding bioassay because significant mortality
did not occur until at least 72 h post-treatment. Aliquots of a 200 mg/mL solution of OA
in acetone were used to dose honey bees in both the range-finding and definitive
bioassays because solutions greater than 200 mg/mL clogged the microsyringe, making it
impossible to deliver accurate doses of OA. The results for the definitive bioassay are
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summarized in Table 1.1. Only the 10 μL acetone control group was used for Probit
analysis of the definitive bioassay data because the 10 μL acetone control had slightly
more mortality than the dry control group. The natural mortality for the definitive
bioassay was 4.0 ± 2.5% after 48 h. I was unable to calculate a confidence interval for
the 72 h LD50 because all bees in the 2000, 1600, 800, and 400 μg OA per bee treatments
died after 72 h. The estimated 72 h LD50 for honey bees was 194.89 μg per bee, based on
the 100 and 200 μg OA per bee treatments.

Discussion
Milani (2001) is the only report that quantifies the toxicity of OA to V. destructor
collected from bee brood, where the 24 h median lethal density (OA density expected to
cause 50% mortality) for V. destructor collected from bee pupae with white eyes was 1.9
μg/cm2 (95% fiducial limits = 1.49 to 2.36). The mites collected from brood were
exposed to OA for 4 h by placing them on glass disks that were sprayed with solutions of
OA. The mites were then transferred to clean glass Petri dishes at 32.5°C and 75%
relative humidity. My results indicate that the 24 h LC50 for phoretic mites is 5.12 μg per
vial. By assuming the area of a single, 20 mL scintillation vial treated with OA was
approximately 20 cm2, the 24 h median lethal density in my study was calculated to be
0.26 μg/cm2. One likely reason for the apparent higher toxicity in my study is that Milani
exposed mites to OA for 4 h versus 24 h in my bioassays. Further, the previous study
used mites collected from brood as experimental material, and I collected mites from
adult bees. Differences between mites collected from adults versus brood could have also
affected bioassay results. However, I believe it is preferable to use phoretic mites for
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conducting OA bioassays because OA does not kill mites in brood when applied to a
hive.
The mode of action for OA is not completely understood. My results suggest that
OA may exhibit its lethal effects on mites via contact. However, I cannot rule out that
some mite mortality was caused by exposure to OA vapors. I expect that mite mortality
resulting from exposure to OA vapors was minimal because OA has a low volatility at
room temperature (vapor pressure < 0.001 mm Hg at 25°C; melting point of 101-102°C)
(Merck Index 1996). Charrière and Imdorf (2002) reported that OA mixed in 1:1 sugar
water exhibits greater miticidal effectiveness than solutions with half as much sugar (1:2
sugar water). Further, Milani (2001) indicates that sucrose and glycerol are synergists of
OA under laboratory conditions due to sucrose’s ability to cause OA to become more
hygroscopic. Perhaps the sugar water solution adheres better to bees, thus increasing
mite exposure to OA.
The 400, 800, 1600, and 2000 μg per bee doses applied in the definitive bioassay
completely covered the bees’ abdomen with OA crystals. Further, the 2000 μg per bee
dose that was delivered in 10 μL of acetone completely soaked the bees with some
runoff. My results indicate that it is nearly impossible to kill 100% of a test population of
adult bees in 24 h by topically applying OA in acetone. I conclude that OA has a
relatively low acute toxicity to honey bees. There are several accounts in the literature of
increased adult bee mortality as a result of OA application within hives (Charrière and
Imdorf 2002, Imdorf et al. 1998), suggesting that OA may not exhibit its lethal effect on
honey bees until more than 24 h after exposure.
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A typical honey bee colony in the North Central Region of the United States has a
November adult bee population of 35,000 bees (personal observation). According to the
Canadian protocol (Special Supplement 2005), a beekeeper would apply a maximum of 2
g OA per hive for Varroa treatment (trickle or vaporizer methods). The resulting dose of
OA per bee would have a maximum value of 57.1 μg per bee (2,000,000 μg OA / 35,000
bees). Results from acute exposure bioassays suggests that 57.1 μg per bee is
considerably below the 48 h LD10 (176.68 μg per bee). My results showed that all bees
dosed with 2000, 1600, 800, or 400 μg OA per bee died after 72 h. Bees subjected to the
100 μg OA per bee dose survived longer than 72 h and had mortality similar to the
control treatment. My results roughly coincide with the recommended dose of OA per
hive (≤ 2 g) because doses ≤ 100 μg OA per bee in my laboratory bioassays did not cause
significant mortality.
My data are significant because they quantify the dosage-mortality relationships
for populations of both mites and bees that have not been exposed to OA. My data will
facilitate future comparisons of toxicity if mite resistance to OA becomes evident.
Further, these basic toxicological properties of the compound will help guide scientists in
developing techniques for delivering optimum dosages to the parasite and its host.

Table 1.1 – Honey bee mortality responses to oxalic acid dihydrate when topically applied to bee abdomens in acetone
and Varroa destructor mortality responses in glass-vial residual bioassays.
Honey bee
mortality

n

Slope ± SE

24 h

280

2.87 ± 0.54

48 h

280

Mite
mortality
24 h

LD10 (95% CL)
(μg per bee)

LD50 (95% CL)
(μg per bee)

LD90 (95% CL)
(μg per bee)

564.05 (95.22 to 877.92)

1,575.85 (1,087.44 to 2,962.72)

4,402.6 (2,541.78 to 48,848.75)

3.96 ± 0.54

176.68 (120.36 to 225.54)

372.01

783.27 (643.5 to 1,042.56)

n

Slope ± SE

LC10 (95% CL)
(μg per 20 mL vial)

LC50 (95% CL)
(μg per 20 mL vial)

LC90 (95% CL)
(μg per 20 mL vial)

320

2.28 ± 0.35

1.4 (0.63 to 2.26)

5.12 (3.47 to 7.0)

18.69 (13.14 to 31.7)

(306.78 to 439.88)
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Chapter 2

Using fall treatments with oxalic acid to reduce Varroa mite populations in the
North Central Region of the United States

Abstract
Field trials were conducted on 52 honey bee colonies to quantify the efficacy of
oxalic acid (OA) against Varroa mites in the North Central Region (NCR) of the United
States. I performed the experiment in November 2004 on colonies that were located in 3
apiaries near Lincoln, NE. The experimental colonies had 1 or 2 hive bodies (24.4 cm
deeps) and contained less than 2 frames of brood. I randomly assigned the Varroainfested colonies to 3 treatment groups: 1) trickle OA, 2) spray OA, and 3) untreated. For
the trickle treatment, I applied 50 mL of a 3.5% OA sugar water solution to both single
and double story colonies using a 100 mL syringe (n = 17). For the spray treatment, I
applied 50 mL of a 3.5% OA sugar water solution to both single and double story
colonies by directly spraying the adult bee cluster from above and below using a 1 L,
non-pressurized sprayer (n = 18). The experiment also included a group of untreated
(control) colonies (n = 17). I determined the pre- and post-treatment Varroa infestation
levels for all colonies and calculated the percentage reduction in Varroa infestation 18
days post-treatment. The trickle treatment reduced Varroa infestation by 77.3 ± 14.1%
when compared to untreated colonies. The spray treatment reduced Varroa infestation by
80.2 ± 14.0% when compared to untreated colonies. The effectiveness of the trickle and
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spray treatments was not significantly different. I conclude that OA is a viable treatment
method for Varroa mites in the NCR of the United States.

Introduction
Honey bee colonies located in the North Temperate Zone (includes Great Britain,
Europe, northern Asia, and North America) decelerate brood rearing in autumn to prepare
for winter. In Nebraska, honey bee colonies have minimal brood by November, and by
December, most colonies are broodless. The broodless condition of honey bee colonies
located in temperate climate zones is ideal for OA application because OA does not kill
mites in sealed brood cells (Schuster and Schürzinger 2003). Oxalic acid is most
effective in broodless colonies because Varroa mites in brood cells are not exposed to
treatments. During broodless periods, all mites are phoretic on adult bees and vulnerable
to treatment.
The objective of this study was to investigate the usefulness of OA for reducing
Varroa mite populations in broodless colonies in the NCR of the United States. At the
time of this study, OA’s efficacy had not been tested in the United States. In contrast,
numerous field studies that quantified the efficacy of OA on broodless colonies had been
published in the European literature and report ~90% efficacy against Varroa when using
either the trickle or spray treatment methods (Imdorf et al. 1995, Charrière and Imdorf
2002, Nanetti et al. 2003, Charrière et al. 2004). My goal was to test the hypothesis that
OA would have an efficacy of ~90% against Varroa mites as reported in the European
literature.
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Materials and Methods
Identification of experimental hives
I established 52 experimental colonies in 3 apiaries near Lincoln, NE in
November 2004. The experimental hives were 1 or 2 stories (24.4 cm deeps) and
contained less than 2 frames of brood.

Treatment and data collection
I randomly assigned the Varroa-infested colonies to 3 treatment groups: 1) trickle
OA, 2) spray OA, and 3) untreated. I collected approximately 300 adult bees in alcohol
from the 52 experimental hives on November 3rd, applied the OA treatments on
November 4th, and collected the post-treatment alcohol samples on November 22nd, 2004.
I estimated the pre- and post-treatment Varroa infestation levels using the alcohol wash
method (Shimanuki and Knox 2000).
For the trickle treatment, I applied 50 mL of a 3.5% OA sugar water (sugar:water)
(1:1) (w:w) solution to both single and double story colonies using a 100 mL syringe (n =
17). I trickled the OA solution from above the frames between each occupied bee-way
and made an effort to maximize contact with the adult bee population. For the spray
treatment, I applied 50 mL of a 3.5% OA sugar water solution (sugar:water) (1:1) (w:w)
to both single and double story colonies by directly spraying the adult bee cluster from
above and below using a 1 L, non-pressurized sprayer (n = 18). The untreated (control)
colonies were left untouched (n = 17). I chose to treat the colonies with 50 mL of a 3.5%
OA sugar water solution based on methods described by Rademacher and Harz (2006).
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I inserted sticky boards and Checkmite+® strips in the hives from 2 of the
apiaries (n = 25) on December 9th and removed them on December 13th, 2004. The
experimental mite populations had not previously exhibited coumaphos resistance. I used
the sticky board counts to determine the remaining mite populations in the experimental
hives 35 days post-treatment.

Experimental design and statistical analysis
I designed my experiment as a randomized complete block design (RCBD)
blocked by the apiaries in which the experimental hives were located (n = 3) to account
for variance in the pre-treatment Varroa mite infestation levels. I used mites-per-100
adult bees as a response variable to test for differences in Varroa infestation between preand post-treatment experimental hives. I used the percentage reduction in Varroa
infestation 18 days post-treatment as another response variable. For the final response
variable, I examined the number of mites remaining 35 days post-treatment in hives
treated with Checkmite+® strips and fitted with sticky boards.
I analyzed the data using PROC MIXED (SAS Institute 2006), and I separated
means using a t-test (α = 0.05). I assumed random blocks, although the assumption of
fixed blocks did not change the results. I applied the Kenwood-Rogers degrees of
freedom adjustment, and used PROC UNIVARIATE and PROC GPLOT (SAS Institute
2006) to verify my assumptions of normality and constant variance.
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Results
My assumptions of normality and constant variance were met. I used the ShapiroWilk test in the UNIVARIATE procedure of SAS to verify normality. The Shapiro-Wilk
test indicated that my data were normal (P = 0.3726) when using either mites-per-100
adult bees or percentage reduction in Varroa infestation as response variables. In
addition, a symmetric box-plot and a straight-lined normal probability plot confirmed
normality. A plot of the residual versus the predicted values revealed no obvious patterns
and was indicative of data that had constant variance.

RCBD with mites-per-100 adult bees as the response variable
I split the 3 treatment groups (trickle OA, spray OA, and untreated) into their preand post-treatment counterparts for this analysis. This resulted in 6 treatment estimates
(pre-trickle, pre-spray, pre-untreated, post-trickle, post-spray, and post-untreated). The
post-treatment estimates are derived from alcohol samples taken 18 days after the pretreatment alcohol samples. The treatment effect was significant (F = 3.71, df = 5, 96.1, P
= 0.0041). A summary of the treatment estimates reported as mites-per-100 adult bees is
provided in Table 2.1. As illustrated in Table 2.1, the pre-trickle, pre-spray, and preuntreated experimental colonies had Varroa infestations ranging from 7.8 to 11.4 mitesper-100 bees and were not significantly different from each other. In contrast, both the
18 d post-trickle and 18 d post-spray treatments had significantly fewer mites than the 18
d post-treatment group that received no treatment (t = 2.52, df = 96, P = 0.0135) (t = 2.76,
df = 96.1, P = 0.0070). The 18 d post-trickle and 18 d post-spray Varroa infestations
were not significantly different (t = 0.21, df = 96.1, P = 0.8310).
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RCBD with percentage reduction in Varroa infestation 18 days post-treatment as the
response variable
The treatment effect was significant (F = 20.87, df = 2, 47.1, P = 0.0001). See
Table 2.2 for a summary of the treatment estimates reported as percentage reduction in
Varroa infestation 18 days post-treatment. The trickle OA treatment significantly
reduced Varroa infestation by 77.3 ± 14.1% when compared to untreated colonies (t =
5.48, df = 46.8, P = 0.0001). Similarly, the spray OA treatment significantly reduced
Varroa infestation by 80.2 ± 14.0% when compared to untreated colonies (t = 5.72, df =
47.2, P = 0.0001). The effectiveness of the trickle OA and spray OA treatments were not
significantly different (t = 0.21, df = 47.2, P = 0.8377).

RCBD with the number of mites remaining 35 days post-treatment as the response
variable
I used the sticky board counts for mites falling during the first 4 days after
CheckMite+® application to determine the remaining mite populations in a portion of the
experimental hives 35 days post-treatment. The treatment effect was significant (F =
13.59, df = 2, 21.4, P = 0.0002). See Table 2.3 for a summary of the number of mites
remaining 35 days post-treatment for each group. The trickle OA treatment significantly
reduced Varroa infestation by 268.4 ± 60.4 mites when compared to untreated colonies (t
= 4.44, df = 21, P = 0.0002). Similarly, the spray OA treatment significantly reduced
Varroa infestation by 278.2 ± 60.8 mites when compared to untreated colonies (t = 4.58,
df = 21.5, P = 0.0002). The number of mites remaining in the trickle OA and spray OA
treatment colonies were not significantly different (t = 0.16, df = 21.5, P = 0.8737).
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Discussion
I accept my hypothesis that OA would have an efficacy of ~90% against Varroa
mites in the NCR of the United States. The trickle OA and spray OA treatments
significantly reduced Varroa infestation by 77.3% (95% CI = 48.9 to 105.7%) and 80.2%
(95% CI = 52.0 to 108.4%) when compared to untreated colonies, respectively. Although
not statistically different, my results showed OA’s average efficacy to be 10 to 13%
lower than the European results which indicated ~90% efficacy against Varroa when
using either the trickle or spray treatment methods on broodless colonies. One possible
explanation as to why OA’s efficacy was numerically lower in my study than European
studies is that I waited 18 days to take the post-treatment alcohol samples. Several of the
colonies had small patches of brood that may have increased Varroa infestation when
they eclosed over the 18 day period between pre- and post-treatment samples. Perhaps I
did achieve ~90% efficacy against Varroa mites on adult bees at the time of treatment,
and the efficacy by day 18 was underestimated due to Varroa mites emerging from
brood.
The effectiveness of the trickle OA and spray OA treatments was not significantly
different. However, the trickle method may be preferable because it was less time and
labor intensive yet had equivalent efficacy when compared to the spray method. It took
about 1.5 minutes to treat a colony using the trickle method and about 5 minutes to treat a
colony using the spray method. This includes removal of the lid and inner cover,
application of OA, and reassembly of the hive.
My results reveal that the trickle OA and spray OA treatments significantly
reduced Varroa infestation regardless of the response variable modeled (mites-per-100
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bees, percentage reduction in Varroa infestation 18 days post-treatment, or the number of
mites remaining 35 days post-treatment). Furthermore, 77.3 to 80.2% reduction in
Varroa infestation is comparable to the efficacies of other Varroa control products on the
market. I conclude that OA is a viable treatment method for Varroa mites in the NCR of
the United States.
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Table 2.1 – Treatment estimates with mites-per-100 adult bees as
the response variable. Estimates with different letters indicate
significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

Pre-trickle

11.4 ± 5.6 a

17

Pre-spray

7.8 ± 5.6 a

18

10.8 ± 5.6 a

17

18 d Post-trickle*

1.8 ± 5.6 b

17

18 d Post-spray

1.1 ± 5.6 b

18

10.5 ± 5.6 a

17

Pre-untreated

18 d Post-untreated
* 18 d = 18 days post-treatment
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Table 2.2 – Treatment estimates with percentage reduction in Varroa
infestation 18 days post-treatment as the response variable.
Estimates with different letters indicate significant differences (t-test,
α = 0.05).
Treatment

Estimate ± Standard error

n

Trickle OA

79.1 ± 14.4 a

17

Spray OA

82.0 ± 14.1 a

18

Untreated

1.8 ± 14.4 b

17

50
Table 2.3 – Treatment estimates with the number of mites
remaining 35 days post-treatment as the response variable.
Estimates with different letters indicate significant differences
(t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

Trickle OA

31.9 ± 47.8 a*

8

Spray OA

22.1 ± 44.6 a

9

Untreated

300.3 ± 47.8 b

8

* The estimates represent the remaining mite populations 35
days post-treatment that were recovered from sticky boards
left in hives for 4 days with Checkmite+® strips present
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Chapter 3

Using summer oxalic acid treatments to reduce Varroa mite populations in colonies
containing brood

Abstract
I conducted a field trial on 46 honey bee colonies to determine the efficacy of
oxalic acid (OA) against Varroa mites in hives containing brood. The experimental hives
were single story, queenright, and contained all stages of worker brood. I randomly
assigned the experimental hives to 4 treatment groups: 1.) untreated or control, 2.) 2.0%
OA, 3.) 3.5% OA, and 4.) 6.0% OA. For the OA treatments, I trickled 50 mL of a 2.0%,
3.5%, or 6.0% OA sugar water solution in the hives using a 100 mL syringe. Each
colony was treated 3 times at 1 week intervals. The experiment also included a group of
untreated colonies. I collected approximately 300 adult bees in alcohol to estimate the
pre- and post-treatment Varroa infestation level on adult bees. I measured the square
inches of capped worker brood, counted the number of frames that the adult bee cluster
occupied, and examined both worker and drone bee pupae from each hive. I counted the
number of adult female Varroa mites on excised bee pupae to estimate the pre- and posttreatment Varroa infestation levels in brood. I also weighed the hives at the end of the
study to quantify the impact of OA treatment on weight gain. Repeated applications of
OA did not significantly reduce the Varroa infestation on adult bees or in brood
regardless of the concentration applied. The number of frames of adult bees, the square
inches of capped worker brood, and the average weight-per-hive were not negatively
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affected by repeated applications of OA. My results do not support the use of OA as a
summer treatment when colonies contain expanded brood nests. Although repeated
treatments exhibited no harmful effects on bees, the paucity of significant mite
population suppression indicates that repeated treatments are not useful in a Varroa
management program.

Introduction
The broodless condition of honey bee colonies located in temperate climate zones
is ideal for OA application because OA does not kill mites in sealed brood cells (Schuster
and Schürzinger 2003). Oxalic acid is most effective in broodless colonies because
Varroa mites in brood cells are not exposed to treatments. During broodless periods, all
mites are phoretic on adult bees and vulnerable to treatment.
The leading objective of the current study was to investigate the usefulness of
repeated mid-summer applications of OA for reducing Varroa mite populations in
colonies containing expanded brood nests. While numerous studies of Varroa control
with OA have been conducted in Europe, Asia, and Canada, few studies have been
conducted in the United States. Most studies report ~90% efficacy against Varroa when
using either the trickle or spray treatment methods (Imdorf et al. 1995, Charrière and
Imdorf 2002, Nanetti et al. 2003, Charrière et al. 2004, Rademacher and Harz 2006).
Schuster and Schürzinger (2003) reported that a single application of OA does not kill
mites in sealed brood cells. My goal was to test the hypothesis that repeated applications
of OA would significantly reduce Varroa mite populations in colonies containing brood.
My theory was that by applying OA 3 times at one week intervals, mites in sealed brood
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cells would eventually come in contact with OA as adult bees emerged over the 14 day
treatment period and mites became phoretic on adult bees. I wanted to establish the
efficacy of 2.0%, 3.5%, and 6.0% OA sugar water solutions. I hypothesized that the
efficacy of OA against Varroa would increase as the concentration of the OA solution
increased, and that 3 successive treatments at 7 day intervals would expose most of the
Varroa population to OA. My final objective was to quantify the impact of repeated
applications of OA on overall colony health by measuring the square inches of capped
worker brood, by counting the number of frames containing adult bees, and by weighing
the colonies at the end of the study.

Materials and Methods
Identification of experimental hives
I established 46 Varroa-infested honey bee colonies in 2 apiaries at the University
of Nebraska-Lincoln’s Agricultural Research and Development Center (ARDC) near
Mead, NE as experimental units for this study. The experimental hives were single story
Langstroth beehives (24.4 cm deep hive body) with a queen excluder and 1 or 2 supers
(16.8 cm deep). The experimental colonies contained 3 to 6 frames of brood, a young
Carniolan or Italian queen, and all frames were covered with bees.

Treatment and data collection
I randomly assigned the 46 experimental hives to 4 treatment groups: 1.)
untreated or control, 2.) 2.0% OA, 3.) 3.5% OA, and 4.) 6.0% OA. The hives were
queenright and contained all stages of worker brood (eggs, larvae, pupae). Not all hives
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contained drone brood. I collected approximately 300 adult bees in alcohol to estimate
the pre-treatment Varroa infestation level on adult bees (July 12). I applied the OA
treatments on July 13, 19, and 27. I collected approximately 300 adult bees in alcohol to
estimate the post-treatment Varroa infestation level on adult bees (August 9).
I measured the square inches of capped worker brood, counted the number of
frames that the adult bee cluster occupied, and excised ~300 worker bee pupae and ~90
drone bee pupae from each hive (July 12 and August 9). I counted the number of adult
female Varroa mites on excised bee pupae to estimate the pre- and post-treatment Varroa
infestation levels in brood. I weighed the hives at the end of the study to quantify the
impact of OA treatment on weight gain (August 9).
For the OA treatments, I trickled 50 mL of either a 2.0%, 3.5%, or 6.0% OA sugar
water (sugar:water) (1:1) (w:w) solution over the cluster of bees using a 100 mL syringe.
I trickled 5-6 mL of the OA solutions between each occupied bee-way and made an effort
to maximize contact with the adult bee population. Each colony was treated 3 times at 1
week intervals (July 13, 19, and 27). The untreated (control) colonies were left
untouched. I chose to treat the hives with 50 mL of the OA sugar water solutions based
on European results reported by Rademacher and Harz (2006).

Experimental design and statistical analysis
I designed my experiment as an randomized complete block design (RCBD). I
blocked by apiary (n = 2) in which the experimental hives were located to account for
variance in the pre-treatment Varroa mite infestation levels. I used mites-per-100 adult
bees pre- and post-treatment, percentage reduction in Varroa infestation 28 days post-
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treatment, and mites-per-100 excised worker and drone pupae pre- and post-treatment as
response variables. Other response variables included the number of frames of adult bees
in each hive pre- and post-treatment, the square inches of capped worker brood pre- and
post-treatment, and the post-treatment weight-per-hive.
I analyzed the mites-per-100 adult bee data, the mites-per-100 excised worker
pupae data, the mites-per-100 excised drone pupae data, and the square inches of capped
worker brood data using PROC GLIMMIX (SAS Institute 2006) and separated means
using a t-test (α = 0.05). I fit a generalized linear model (GLM) for each of the
aforementioned response variables using a normal distribution. I also assumed random
blocks, although the assumption of fixed blocks did not change the results. I framed my
data as a factorial with dose and time as factors. Time had 2 levels: pre- and posttreatment. Dose had 4 levels: 0 (untreated), 2.0% OA, 3.5% OA, and 6% OA. For the
above analyses, there were 8 total treatment combinations (pre-untreated, pre-2.0% OA,
pre-3.5% OA, pre-6.0% OA, post-untreated, post-2.0% OA, post-3.5% OA, and post6.0% OA). I applied the ‘group=dose’ option in PROC GLIMMIX to fit a separate
variance for each dosage of OA. I used PROC UNIVARIATE (SAS Institute 2006) to
verify my assumption of normality.
I also analyzed the number of frames of adult bees data using PROC GLIMMIX
(SAS Institute 2006) and separated means using a t-test (α = 0.05). This data set differed
from the abovementioned response variables because the data were frame counts (1 to 9
frames). For this response variable, I fit a GLM and implemented the Poisson
distribution in PROC GLIMMIX.
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I analyzed the percentage reduction in Varroa infestation 28 days post-treatment
data and the post-treatment weight-per-hive data using PROC GLIMMIX (SAS Institute
2006) and separated means using a t-test (α = 0.05). I fit a GLM for the percentage
reduction and weight-per-hive response variables using a normal distribution. I assumed
random blocks, although the assumption of fixed blocks did not change the results. I
considered 4 treatments for the percentage reduction in Varroa infestation 28 days posttreatment data (untreated, 2.0% OA, 3.5% OA, and 6.0% OA). The percentage reduction
in Varroa infestation was calculated for each hive using the pre- and post-treatment
mites-per-100 adult bee data. I considered 4 treatments for the post-treatment weightper-hive data (post-untreated, post-2.0% OA, post-3.5% OA, and post-6.0% OA). I
applied the ‘group=treatment’ option in PROC GLIMMIX to fit a separate variance for
each treatment. I used PROC UNIVARIATE (SAS Institute 2006) to verify my
assumption of normality.

Results
My assumption of normality was met for all response variables for which I fit a
GLM using a normal distribution. These data sets produced a symmetric box-plot and a
straight-lined normal probability plot that confirmed normality. A plot of the residual
versus the predicted values revealed a problem with non-constant variance. The
‘group=dose’ option and the ‘group=treatment’ option that I employed in PROC
GLIMMIX fixed the non-constant variance issue. After fitting a separate variance for
each treatment, a plot of the residual versus the predicted values revealed no obvious
patterns and was indicative of data that had constant variance.
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Number of bees collected for adult and brood samples
The average number of adult bees collected in alcohol was 306.8 ± 41.2 (n = 92)
for each pre- and post-treatment sample. The average was calculated using both pre- and
post-treatment alcohol samples for each hive (46 experimental hives X 2 sample times =
92 adult bee alcohol samples). The average number of worker and drone brood cells
excised for pre- and post-treatment sample is shown in Table 3.1.

RCBD with mites-per-100 adult bees as the response variable
There was no significant time*dose interaction (F = 0.18, df = 3, 83, P = 0.9091),
and therefore, the main effects of time and dose were considered. The time effect was
significant (F = 20.69, df = 1, 83, P = 0.0001). Prior to OA treatment, the hives had 2.5 ±
0.5 more mites-per-100 adult bees than after OA treatment regardless of the OA
concentration applied (t = 4.55, df = 83, P = 0.0001). The dose effect was not significant
(F = 1.13, df = 3, 83, P = 0.3411). See Table 3.2 for the treatment estimates with mitesper-100 adult bees as the response variable.

RCBD with percentage reduction in Varroa infestation 28 days post-treatment as the
response variable
The treatment effect was not significant at α = 0.05 (F = 1.99, df = 3, 41, P =
0.1302). See Table 3.3 for the treatment estimates with percentage reduction in Varroa
infestation 28 days post-treatment as the response variable. Although the treatment effect
was not significant at α = 0.05, it is important to note that when using α = 0.1, the 6.0%
OA treatment significantly reduced Varroa infestation by 35.4 ± 18.6% when compared
to untreated colonies (t = 1.90, df = 41, P = 0.0640). Similarly, when using the α = 0.1
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significance level, the 6.0% OA treatment significantly reduced Varroa infestation by
29.0 ± 16.1% when compared to the 2.0% OA treatment (t = 1.80, df = 41, P = 0.0792).

RCBD with mites-per-100 excised worker pupae as the response variable
There was significant time*dose interaction (F = 2.30, df = 3, 63, P = 0.0858) at
the α = 0.1 significance level, and therefore, the simple effects of time and dose were
considered. When only considering the post-treatment time effect, the untreated hives
had 0.7 ± 0.4 more mites-per-100 excised worker pupae than the hives that received the
3.5% OA treatment (t = 2.01, df = 63, P = 0.0484). When only considering the posttreatment time effect, the untreated hives had 0.7 ± 0.3 more mites-per-100 excised
worker pupae than the hives that received the 6.0% OA treatment (t = 2.18, df = 63, P =
0.0329). When only considering the pre-treatment time effect, the hives slated to receive
the 2.0% OA treatment had 0.7 ± 0.3 more mites-per-100 excised worker pupae than the
hives slated to receive the 6.0% OA treatment (t = 2.30, df = 63, P = 0.0245). When only
considering the pre-treatment time effect, the hives slated to receive the 3.5% OA
treatment had 0.7 ± 0.3 more mites-per-100 excised worker pupae than the hives slated to
receive the 6.0% OA treatment (t = 2.35, df = 63, P = 0.0220). When only considering
the hives that received the 3.5% OA treatment, there were 1.0 ± 0.4 more mites-per-100
excised worker pupae prior to OA treatment than after OA treatment (t = 2.92, df = 63, P
= 0.0049). See Table 3.4 for the treatment estimates with mites-per-100 excised worker
pupae as the response variable.
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RCBD with mites-per-100 excised drone pupae as the response variable
There was no significant time*dose interaction (F = 0.32, df = 3, 41, P = 0.8114),
and therefore, the main effects of time and dose were considered. The time effect was
not significant (F = 1.23, df = 1, 41, P = 0.2734). The dose effect was also not significant
(F = 0.36, df = 3, 41, P = 0.7826). See Table 3.5 for the treatment estimates with mitesper-100 excised drone pupae as the response variable.

RCBD with the number of frames of adult bees in each hive as the response variable
There was no significant time*dose interaction (F = 0.10, df = 3, 83, P = 0.9587),
and therefore, the main effects of time and dose were considered. The time effect was
not significant (F = 1.02, df = 1, 83, P = 0.3184). The dose effect was not significant (F
= 0.13, df = 3, 83, P = 0.9443). See Table 3.6 for the treatment estimates with the
number of frames of adult bees in each hive as the response variable.

RCBD with the square inches of capped worker brood in each hive as the response
variable
There was no significant time*dose interaction (F = 0.42, df = 3, 83, P = 0.7390),
and therefore, the main effects of time and dose were considered. The time effect was
not significant (F = 1.37, df = 1, 83, P = 0.2444). The dose effect was not significant (F
= 0.85, df = 3, 83, P = 0.4731). See Table 3.7 for the treatment estimates with the square
inches of capped worker brood in each hive as the response variable.
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RCBD with the weight-per-hive (lbs) 28 days post-treatment as the response variable
The treatment effect was not significant (F = 1.70, df = 3, 41, P = 0.1819). See
Table 3.8 for the treatment estimates with the weight-per-hive 28 days post-treatment as
the response variable.

Discussion
I reject my hypothesis that repeated applications of OA would significantly
reduce Varroa mite populations in colonies containing brood. There was an overall
percentage reduction in the Varroa mite populations on adult bees regardless of treatment
(Table 3.3). The mites-per-100 adult bee data coincide with the percentage reduction in
Varroa infestation data as the hives had 2.5 ± 0.5 more mites-per-100 adult bees prior to
OA treatment than after OA treatment. Again, treatment with OA did not significantly
reduce the number of mites on adult bees regardless of the concentration applied (Table
3.2).
The 6.0% OA treatment significantly reduced Varroa infestation by 35.4 ± 18.6%
when compared to untreated colonies (α = 0.1 level of significance). Similarly, the 6.0%
OA treatment significantly reduced Varroa infestation by 29.0 ± 16.1% when compared
to the 2.0% OA treatment (α = 0.1 level of significance). I do not consider the above
treatment differences important because both the probability of Type I error and the
variation in percentage reduction are large. Furthermore, the percentage reduction
achieved with the 6.0% OA treatment is significantly less than other Varroa control
products on the market.
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I am puzzled by the result that the untreated colonies had a 37.4 ± 17.2% decrease
in Varroa infestation. One possible reason that the Varroa population decreased on adult
bees in control colonies is that one of the experimental apiaries was exposed to full
sunlight for the majority of the day (n = 32). The average maximum daily temperature
during the experiment was 35.1 ± 2.6°C (95.1 ± 4.6°F). Aliano and Ellis (2005a) report
that heat significantly increases the number of mites that fall from adult bees at
temperatures ≥ 35°C. I noticed large clusters of adult bees hanging on the outside of the
colonies above the entrances that were fanning air currents to cool the colonies during hot
periods of the day. Perhaps mites fell from the adult bee clusters outside of the hive and
were not able to reenter the colony. Another possibility is that the internal colony
temperature was not being adequately controlled by the bee population and mites fell or
were injured due to extreme temperatures. One problem with the above explanations is
that there was a significant decrease in Varroa infestation in the control colonies when
only considering the apiary that had moderate shade (n = 14).
A final explanation for why the Varroa population decreased on adult bees in the
control colonies is that mites may have migrated to drone brood as it became available
during the study. Approximately half of the colonies did not have appropriately aged
drone brood to sample for mites at the end of the study (n = 21) (pupae with purple eyes)
but the majority of the colonies had recently capped drone brood present.
I reject my hypothesis that the efficacy of OA would increase as the concentration
of the OA solution increased in colonies containing brood. As Table 3.3 illustrates, the
efficacy of OA numerically increased as the OA concentration increased, but the
differences were not significant. It is interesting that the treatment standard errors
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decreased as the OA concentration increased. The fact that the variance in Varroa
infestation went down as OA concentration increased makes biological sense because
more of the mites theoretically died as more OA was applied.
The analysis of the mites-per-100 excised worker pupae data is difficult to
interpret because there were significantly more mites in the hives slated to receive the
2.0% and 3.5% OA treatment than the hives slated to receive the 6.0% OA treatment.
Although the untreated hives had 0.7 more mites-per-100 excised worker pupae than the
hives that received the 3.5% OA treatment or the 6.0% OA treatment, the differences
may be fictitious because the pre-treatment Varroa infestation in worker brood was not
constant among the treatments (Table 3.4). In contrast, the mites-per-100 excised drone
pupae data indicates that the Varroa infestation in drone brood was not significantly
different between the treatment groups before or after OA application (Table 3.5). I place
more importance on the mites-per-100 excised drone pupae data because Varroa mites
preferentially parasitize drone brood over worker brood, and drone brood is often 8-10
times more infested than worker brood (Fuchs 1990). Similar to the mites-per-100 adult
bee data and the percentage reduction in Varroa infestation data, the mites-per-100
excised drone pupae data indicates that OA did not significantly reduce Varroa mite
populations in colonies containing brood.
The final objective of this experiment was to quantify the impact of repeated
applications of OA on overall colony health by measuring the square inches of capped
worker brood, by counting the number of frames containing adult bees, and by weighing
the colonies at the end of the study. As illustrated in Tables 3.6, 3.7, and 3.8, the number
of frames of adult bees, the square inches of capped worker brood, and the average
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weight-per-hive were not significantly influenced by repeated applications of OA,
regardless of the OA concentration. My results indicate that summer bees can tolerate
larger amounts of OA than reported in the literature for autumn or winter bees. Liebig
(1998) and Charrière (2001) quantified the impact on autumn or winter colonies when
applying OA solutions with concentrations greater than 5% and described significant
adult bee mortality, poor over-wintering ability, and impaired spring development. My
data suggests that 3 summer trickle treatments with 6.0% OA at one week intervals did
not have a negative impact on colony health.
I conclude that repeated applications of OA did not significantly reduce Varroa
mite populations in honey bee colonies when brood was present. My results confirm the
observations that OA is less effective when significant brood is present (Fuchs 1990,
Gregorc 2001). One possible reason for the poor efficacy of OA in the presence of brood
may be that brood provides a robust buffer that counteracts phoretic mite mortality.
Another reason for the poor efficacy of mid-summer use of OA may be inadequate
distribution of OA among the adult bee population. Unlike OA treatments in the fall or
early winter, mid-summer bees do not cluster, which may result in OA missing the
majority of adult bees. Furthermore, mid-summer use of OA may result in rapid
evaporation of the OA crystals due to heat and excessive fanning of the hive by adult
bees for cooling purposes. My results do not support the mid-summer use of OA to
reduce Varroa populations which agrees with observation in Europe (Rademacher and
Harz 2006).
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Table 3.1 – Average number of brood cells excised for pre- and
post-treatment sample. The estimates were calculated using both
the pre- and post-treatment brood samples for each hive.
Brood type

Estimate ± Standard error

n*

Worker

304.7 ± 75.6

86

Drone

88.9 ± 38.1

60

* 43 of the 46 experimental hives had available worker brood to sample
* 30 of the 46 experimental hives had available drone brood to sample
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Table 3.2 – Treatment estimates with mites-per-100 adult bees as the
response variable. The estimates represent the Varroa infestation of
adult bees prior to and after treatment with OA. Estimates with
different letters indicate significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

*Pre-untreated

3.8 ± 1.4 a

12

Pre-OA 2.0%

4.3 ± 1.5 a

12

Pre-OA 3.5%

3.5 ± 1.5 a

11

Pre-OA 6.0%

3.2 ± 1.2 a

11

*Post-untreated

1.9 ± 1.4 b

12

Post-OA 2.0%

1.6 ± 1.5 b

12

Post-OA 3.5%

0.5 ± 1.5 b

11

Post-OA 6.0%

0.9 ± 1.2 b

11

* Average pre-treatment estimate summed over OA
concentration = 3.7 ± 1.2 mites-per-100 adult bees
* Average post-treatment estimate summed over OA
concentration = 1.2 ± 1.2 mites-per-100 adult bees
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Table 3.3 – Treatment estimates with percentage
reduction in Varroa infestation 28 days post-treatment as
the response variable. Estimates with different letters
indicate significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

Untreated

37.4 ± 17.2 a

12

OA 2.0%

43.7 ± 14.5 a

12

OA 3.5%

55.7 ± 13.8 a

11

OA 6.0%

72.8 ± 8.0 a

11
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Table 3.4 – Treatment estimates with mites-per-100 excised
worker pupae as the response variable. The estimates represent
the Varroa infestation of worker brood prior to and after
treatment with OA. Estimates with different letters indicate
significant differences (t-test, α = 0.05).
Treatment

1

Estimate ± Standard error

n3

1

Pre-untreated

0.8 ± 0.3 ab4

10

Pre-OA 2.0%

1.3 ± 0.3 b

11

Pre-OA 3.5%

1.3 ± 0.3 b

5

Pre-OA 6.0%

0.6 ± 0.3 a

10

2

Post-untreated

1.0 ± 0.3 a

10

Post-OA 2.0%

0.7 ± 0.3 ab

11

Post-OA 3.5%

0.3 ± 0.3 b

5

Post-OA 6.0%

0.4 ± 0.3 b

10

Average pre-treatment estimate summed over OA concentration =
1.0 ± 0.2 mites-per-100 excised worker pupae
2
Average post-treatment estimate summed over OA concentration =
0.6 ± 0.2 mites-per-100 excised worker pupae
3
Hives with non-detectable mites pre- and post-treatment were
eliminated from the analysis
4
This table does not consider comparisons between treatments above
and below the double line
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Table 3.5 – Treatment estimates with mites-per-100 excised drone
pupae as the response variable. The estimates represent the Varroa
infestation of drone brood prior to and after treatment with OA.
Estimates with different letters indicate significant differences (t-test,
α = 0.05).
Treatment

Estimate ± Standard error

n3

10.6 ± 5.7 a

6

Pre-OA 2.0%

8.6 ± 6.0 a

8

Pre-OA 3.5%

9.6 ± 8.4 a

3

Pre-OA 6.0%

12.5 ± 6.6 a

8

Post-untreated

10.6 ± 5.7 a

6

Post-OA 2.0%

7.3 ± 6.0 a

8

Post-OA 3.5%

2.0 ± 8.4 a

3

Post-OA 6.0%

6.2 ± 6.6 a

8

Pre-untreated

1

2

Average pre-treatment estimate summed over OA
concentration = 10.3 ± 5.3 excised drone pupae
2 Average post-treatment estimate summed over OA
concentration = 6.5 ± 5.3 excised drone pupae
3
Hives with zero mites pre- and post-treatment were
eliminated from the analysis
1
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Table 3.6 – Average number of frames of adult bees in each hive.
Estimates with different letters indicate significant differences (t-test,
α = 0.05).
Treatment

Estimate ± Standard error

n

*Pre-untreated

6.8 ± 0.8 a

12

Pre-OA 2.0%

7.2 ± 0.8 a

12

Pre-OA 3.5%

7.2 ± 0.8 a

11

Pre-OA 6.0%

7.6 ± 0.8 a

11

*Post-untreated

7.8 ± 0.8 a

12

Post-OA 2.0%

8.0 ± 0.8 a

12

Post-OA 3.5%

7.5 ± 0.8 a

11

Post-OA 6.0%

7.8 ± 0.8 a

11

* Average pre-treatment estimate summed over OA concentration =
7.2 ± 0.4 frames of adult bees
* Average post-treatment estimate summed over OA concentration =
7.8 ± 0.4 frames of adult bees
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Table 3.7 – Average square inches of capped worker brood in
each hive. Estimates with different letters indicate significant
differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

*Pre-untreated

308.0 ± 39.7 a

12

Pre-OA 2.0%

294.4 ± 47.8 a

12

Pre-OA 3.5%

263.0 ± 50.6 a

11

Pre-OA 6.0%

322.5 ± 40.7 a

11

*Post-untreated

364.3 ± 39.7 a

12

Post-OA 2.0%

332.0 ± 47.8 a

12

Post-OA 3.5%

294.8 ± 50.6 a

11

Post-OA 6.0%

314.2 ± 40.7 a

11

* Average pre-treatment estimate summed over OA concentration =
297.0 ± 32.9 square inches of worker brood
* Average post-treatment estimate summed over OA concentration =
326.3 ± 32.9 square inches of worker brood

71
Table 3.8 – Average weight-per-hive 28 days post-treatment.
Estimates with different letters indicate significant differences
(t-test, α = 0.05).
Treatment

Estimate (lbs) ± Standard error

n

Untreated

117.3 ± 23.5 a

12

OA 2.0%

111.9 ± 23.2 a

12

OA 3.5%

97.3 ± 22.1 a

11

OA 6.0%

112.7 ± 22.1 a

11
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Chapter 4

Oxalic acid – a prospective tool for reducing Varroa mite populations in package
bees: Part I – Laboratory evaluation

Abstract
Numerous studies have investigated using oxalic acid (OA) to control Varroa
mites in honey bee colonies. In contrast, techniques for treating package bees with OA
have not been investigated. The goal of this study was to develop a protocol for using
OA to reduce mite infestation in package bees. I made 97 mini packages of Varroainfested adult bees. Each package contained 1613 ± 18 bees, 92 ± 3 mites, and
represented an experimental unit. I prepared a 2.8% solution of OA by mixing 35 g OA
with 1 L of sugar water (sugar:water) (1:1) (w:w). Eight treatments were assigned to the
packages based on previous laboratory bioassays which characterized the acute contact
toxicity of OA to mites and bees. I administered the treatments by spraying the OA
solution directly on the bees through the mesh screen cage using a pressurized air brush
and quantified mite and bee mortality over a 10 day period. My results support applying
an optimum volume of 3.0 mL of a 2.8% OA solution per 1000 bees to packages for
effective mite control with minimal adult bee mortality. The outcome of my research
provides beekeepers and package bee shippers guidance for using OA to reduce mite
populations in package bees.
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Introduction
Numerous studies have investigated using oxalic acid (OA) to control Varroa
mites in honey bee colonies. In contrast, techniques for treating package bees with OA
have not been investigated. A review of literature regarding the efficacy of OA
(Rademacher and Harz 2006) indicates that broodless colonies are ideal for OA
application. Oxalic acid does not kill mites in sealed brood cells (Schuster and
Schürzinger 2003), and it is less effective when brood is present (Fuchs 1990, Gregorc
2001). Oxalic acid is most effective in broodless colonies because Varroa mites are
phoretic on adult bees, and mites inevitably come in physical contact with OA when it is
applied.
Treating package bees with OA is a logical extension of the usefulness of OA as a
Varroa mite control agent because all mites present in packages are phoretic on adult
bees. The goal of this study was to develop a protocol for using OA to reduce mite
infestation in package bees. This study establishes an optimum volume of a 2.8% OA
solution for spraying on package bees to provide effective mite control while minimizing
adult bee mortality.

Materials and Methods
Stocking of packages
I shook 25 kg of Varroa-infested adult honey bees from 20 source colonies into a
bulk bee box on the evening of May 25th, 2006. The source colonies were located at the
University of Nebraska-Lincoln’s Agricultural Research and Development Center
(ARDC) near Mead, NE. I had previously caged the queens from the source colonies to
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ensure that all mites were phoretic on adult bees (May 5). The source colonies were 2 or
3 stories high and were composed of a mixture of Italian and Carniolan bees. I added 1
frame of honey, 2 frames of pollen and nectar, 1 frame of unsealed brood, and 1 frame
with 15 caged queens to stabilize the bulk bee box. In addition, I fit the bulk bee box
with top feeders that contained 6 L of light syrup and 3 L of water. I maintained the bulk
box overnight to allow the bees to cluster and the mite population to become equally
distributed.
The next day, I made 97 packages of adult bees by subdividing the adult bee
population in the bulk bee box (May 6). The dimensions of the packages were 10.2 cm
long, 8.3 cm wide, and 17.8 cm high (Figure 4.1). I provided each package with a 0.5 L
scoop of adult bees. Each package contained 1613 ± 18 bees and 92 ± 3 mites. I moved
the packages to a dark, air-conditioned laboratory where I fit each package with a 0.5 L
top feeder containing light syrup (sugar:water) (1:1) (w:w). I placed 3 large fans in the
laboratory to remove CO2 and to prevent the packages from overheating. The daily
temperature and relative humidity inside the laboratory averaged 23 ± 2°C (n = 6) and
63.6 ± 9% (n = 6), respectively.

Determination of the OA concentration and volumes to apply to the packages
The Canadian Honey Council has provided the American Beekeeping Federation
their registration data packet to expedite the registration of OA in the United States. As a
result, the recommended concentration of the OA solution that will appear on the United
States label will most likely be identical to the Canadian label. Therefore, I chose to test
one concentration of OA based on the Canadian treatment recommendations for honey
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bee colonies. The Canadian label recommends dissolving 35 g of OA dihydrate in 1 L of
warm syrup made from a mixture of sugar and water (sugar:water) (1:1) (weight:volume)
(Special Supplement 2005). This mixture results in a 2.8% OA sugar water solution by
weight (sugar:water) (1:1) (w:w).
I used the bioassay data from chapter 1 to determine the maximum volume of OA
to apply to the packages. The bioassay data estimated the 48 hour LD50 for adult honey
bees to be 372 µg per bee (95% CL = 307 to 440 µg per bee) (Table 1.1). I picked a high
volume of 15 mL of a 2.8% OA solution per package to approximate a dose that was
slightly less than the 48 hour LD50 for adult honey bees (equivalent to 9.3 mL per 1000
bees). A volume greater than 15 mL may have resulted in the premature death of
packages so I decided to err on the side of caution. My calculations were as follows: 35
g of OA in 1 L of sugar water results in approximately 0.035 g OA/mL solution. 15 mL
of OA solution X 0.035 g OA/mL solution = 0.525 g OA per package (525,000 µg per
package). 525,000 µg per package / 1618 bees per package = 325 µg per bee.
I chose 8 volumes of OA to apply to the packages: 0, 1, 3, 5, 7, 9, 11, and 15 mL
of a 2.8% OA solution per package. The above volumes are equivalent to 0.0, 0.6, 1.8,
3.1, 4.6, 5.4, 6.7, and 9.3 mL of a 2.8% OA solution per 1000 bees, respectively.

Treatment and data collection
I randomly assigned the 97 packages to the 8 treatment groups defined above. I
prepared a 2.8% solution of OA by mixing 35 g OA with 1 L of sugar water (sugar:water)
(1:1) (w:w). I administered the treatments by spraying the OA solution directly on the
bees through the mesh screen cage using a pressurized air brush (King Spark Hardware &
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Tool Corporation, model AB-105, Taichung County, Taiwan) (Figure 4.2). I pipetted the
appropriate volume of OA solution into the air brush gravity cup (paint cup) for each
treatment and sprayed the adult bee cluster until the solution was gone. I made an effort
to maximize OA contact with the adult bees by spraying both sides of the screen cages.
I placed sticky boards in the packages prior to OA application to monitor mite
fall. I replaced the sticky boards 3, 6, and 10 days post-treatment to estimate 3, 6, and 10
day Varroa mite mortality. In addition, I recovered dead bees 3, 6, and 10 days posttreatment by removing them from the packages (Figure 4.3). I chilled the packages at
2°C for 20 minutes to force the bees to cluster and facilitate dead bee recovery (3, 6, and
10 days post-treatment). The packages had a sliding screened side that allowed me to
remove dead bees from the bottom of the packages while leaving the cluster of live bees
undisturbed. After counting the number of dead bees at each time interval, I washed the
bees in alcohol to recover the mites that had fallen into the pile of dead bees instead of
landing on the sticky boards below. I added the number of mites collected on the sticky
boards to the number of mites collected from the dead bees to estimate the Varroa mite
mortality for each time interval.
At the end of the experiment, I killed and counted the remaining bees in the
packages by spraying them with 70% alcohol. In addition, I recovered the remaining
mites using the alcohol wash method (Shimanuki and Knox 2000). I was able to
calculate the total number of bees and mites present in each package prior to OA
application by destructively sampling the packages at the end of the experiment.
Specifically, I added the number of mites collected from sticky boards and dead bees 3, 6,
and 10 days post-treatment to the number of mites collected from live bees at the end of
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the experiment to calculate the total number of mites present in each package prior to
experimentation. Similarly, I added the number of dead bees collected 3, 6, and 10 days
post-treatment to the number of live bees remaining at the end of the experiment to
calculate the total number of bees present in each package prior to experimentation. This
enabled me to calculate the proportion of mites and bees killed in each package 3, 6, and
10 days post-treatment. The 97 packages contained a total of 9,309 mites and 162,934
bees.

Experimental design and statistical analysis
I designed my experiment as a completely randomized design (CRD). I used the
proportion of mites and bees killed 3, 6, and 10 days post-treatment as response variables.
I used PROC GLIMMIX to analyze both the mite and bee proportion data and used a
binomial response distribution (SAS Institute 2006). I fit a generalized linear model
(GLM) with a binomial response distribution implemented in PROC GLIMMIX. I
separated means using a t-test (α = 0.05). In addition to the PROC GLIMMIX analysis, I
fit the same model using the NLMIXED procedure (SAS Institute 2006) to calculate the
lethal doses (LD’s) for both mites and bees 3, 6, and 10 days post-treatment.

Results
Lethal doses of OA for mites and bees
Tables 4.1 and 4.2 lists honey bee and Varroa mite mortality responses to a 2.8%
OA solution when sprayed on package bees, respectively. Note that Tables 4.1 and 4.2
list the LD50 3, 6, and 10 days post-treatment. In addition, Table 4.2 lists the LD90 and
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LD95 for mites while Table 4.1 lists the LD10 and LD15 for honey bees because my
objective was to choose a dose that provided effective mite control while minimizing
adult bee mortality.

CRD with the proportion of mites killed 3, 6, and 10 days post-treatment as the response
variable
I modeled the factors time, volume, and the time*volume interaction. The
time*volume interaction was not significant (F = 0.06, df = 14, 267, P = 1.0000). The
time effect was also not significant (F = 0.27, df = 2, 267, P = 0.7655), indicating that
mite mortality 3 days post-treatment was not significantly different than mite mortality 6
or 10 days post-treatment. The volume effect was significant (F = 10.09, df = 7, 267, P =
0.0001). Table 4.3 lists the main effect estimates of the proportion of mites killed for
each of the 8 volumes. Volumes ≥ 3.1 mL of a 2.8% OA solution per 1000 bees resulted
in ≥ 94% mite mortality. In addition, increasing the volume above 3.1 mL per 1000 bees
did not significantly increase mite mortality. Figure 4.4 illustrates the Varroa mite
mortality response to a 2.8% OA solution when sprayed on package bees. The standard
error bars were intentionally not included in Figure 4.4 because they overlap for each
time interval and clutter the graph. The standard error for each volume is listed in Table
4.3.
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CRD with the proportion of bees killed 3, 6, and 10 days post-treatment as the response
variable
I modeled the factors time, volume, and the time*volume interaction. The
time*volume interaction was not significant (F = 0.05, df = 14, 267, P = 1.0000). The
time effect was not significant (F = 2.61, df = 2, 267, P = 0.0756), indicating that bee
mortality 3 days post-treatment was not significantly different than bee mortality 6 or 10
days post-treatment. The volume effect was significant (F = 7.67, df = 7, 267, P =
0.0001). Table 4.4 lists the main effect estimates of the proportion of bees killed for each
of the 8 volumes. In general, volumes ≥ 4.6 mL of a 2.8% OA solution per 1000 bees
caused significant adult bee mortality when compared to untreated packages. Figure 4.5
illustrates the adult bee mortality response to a 2.8% OA solution when sprayed on
package bees. The standard error bars were intentionally not included in Figure 4.5
because they overlap for each time interval and clutter the graph. The standard error for
each volume is listed in Table 4.4.

Discussion
The data collected from this experiment indicate an optimum volume of a 2.8%
OA solution that provides effective mite control while minimizing adult bee mortality
when sprayed on package bees. I recommend applying 3.0 mL of a 2.8% OA sugar water
solution (sugar:water) (1:1) (w:w) per 1000 bees to packages for > 90% mite control and
no significant bee mortality. The OA solution should be applied to packages once the
adult bees have clustered to maximize contact.
I chose to make my recommendation for treating package bees with OA based on
the 6 day Varroa mite LD90 because the 3 day and 10 day time intervals are not realistic.
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For example, bees must remain in their package for at least 3 days before they
biologically become a swarm (personal observation). In general, beekeepers do not
install packages 3 days after they were created because of additional shipping transit
time. The 10 day time interval is also unrealistic because significant bee mortality occurs
if packages are left caged for 10 days. The 6 day time interval is the most realistic
because it factors in the 3 days that are necessary for a package to become a swarm and it
accounts for shipping transit time.
My recommendation for treating packages with OA is based on achieving > 90%
mite mortality and < 10% adult bee mortality as described below. Table 4.2 indicates
that the 6 day Varroa mite LD90 was 2.98 mL of a 2.8% OA solution per 1000 bees. In
addition, Table 4.3 indicates that there was no significant difference between the
proportions of mites killed on package bees when volumes ≥ 3.1 mL per 1000 bees were
applied (0.94 to 0.99). From the mite mortality perspective, 3.0 mL per 1000 bees is the
ideal volume to apply to packages.
Table 4.4 indicates that volumes ≥ 4.6 mL per 1000 bees caused significant adult
bee mortality when compared to untreated packages. From the bee data perspective, 3
mL per 1000 bees is the ideal volume because it does not cause significant bee mortality.
The 3.1 mL per 1000 bee volume resulted in 10% greater bee mortality than untreated
packages, however, the mortality was not significantly different from untreated packages
(Table 4.4).
The easiest method for preparing a 2.8% solution of OA is to mix 35 g OA
dihydrate with 1 L of warm sugar water (Special Supplement 2005). Although a
pressurized air brush was used to apply small volumes of the OA solution in this study,
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beekeepers may use a non-pressurized spray bottle to apply the OA. Simply add the
appropriate volume to the bottle and spray the adult bee cluster within the package until
the solution is gone. Another option for OA application is a MeterJet™ Spray Gun Kit.
The MeterJet™ Spray Gun can be attached to a Solo®, D.B. Smith®, or SP Systems™
sprayer and delivers a precise metered volume of solution with each pull of the trigger.
The MeterJet™ Spray Gun Kit can be purchased from various forestry supply companies
such as Forestry Suppliers Inc. (http://www.forestrysuppliers.com/product_pages/View_Catalog_Page.asp?mi=1853) (accessed January 1,
2008).
My recommendation for treating package bees is useful because it provides
beekeepers and package bee shippers guidance for using OA to reduce mite populations
from package bees or bulk bee boxes. My data indicate that small deviations in the
amount of OA applied to packages result in drastically different outcomes. For example,
although the 3.1 mL per 1000 bees volume did not cause significant bee mortality, the 4.6
mL per 1000 bees volume caused significant bee mortality. Therefore, the applicator
should emphasize accurate measurements when mixing and applying OA to package
bees.

Table 4.1 – Honey bee mortality responses to a 2.8% OA solution when sprayed on package bees.
Honey bee
mortality

n

LD50 (95% CL)
(mL per 1000 bees)

LD15 (95% CL)
(mL per 1000 bees)

LD10 (95% CL)
(mL per 1000 bees)

3d

162,934

7.97 (7.93 to 8.01)

3.80 (3.77 to 3.84)

2.60 (2.56 to 2.64)

6d

162,934

7.45 (7.41 to 7.48)

3.28 (3.24 to 3.31)

2.08 (2.04 to 2.12)

10 d

162,934

6.16 (6.13 to 6.19)

2.00 (1.96 to 2.03)

0.79 (0.75 to 0.84)
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Table 4.2 – Varroa mite mortality responses to a 2.8% OA solution when sprayed on package bees.
Mite
mortality

n

LD95 (95% CL)
(mL per 1000 bees)

LD90 (95% CL)
(mL per 1000 bees)

LD50 (95% CL)
(mL per 1000 bees)

3d

9,309

3.83 (3.74 to 3.91)

3.25 (3.18 to 3.33)

1.57 (1.51 to 1.62)

6d

9,309

3.55 (3.47 to 3.64)

2.98 (2.91 to 3.05)

1.29 (1.23 to 1.35)

10 d

9,309

3.41 (3.32 to 3.49)

2.83 (2.76 to 2.90)

1.14 (1.08 to 1.20)
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Table 4.3 – Estimates of the proportion of Varroa mites killed
when package bees were sprayed with a 2.8% OA solution.
Estimates with different letters indicate significant differences (ttest, α = 0.05).
Volume
(mL per 1000 bees)

Estimate ± Standard error

n

0.0

0.07 ± 0.04 a

36

0.6

0.22 ± 0.07 b

36

1.8

0.76 ± 0.07 c

36

3.1

0.94 ± 0.04 d

42

4.6

0.97 ± 0.03 d

36

5.4

0.99 ± 0.02 d

36

6.7

0.98 ± 0.03 d

30

9.3

0.99 ± 0.02 d

39
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Table 4.4 – Estimates of the proportion of honey bees killed when
packages were sprayed with a 2.8% OA solution. Estimates with
different letters indicate significant differences (t-test, α = 0.05).
Volume
(mL per 1000 bees)

Estimate ± Standard error

n

0.0

0.05 ± 0.04 a

36

0.6

0.07 ± 0.04 a

36

1.8

0.10 ± 0.05 ab

36

3.1

0.15 ± 0.05 ab

42

4.6

0.22 ± 0.07 bc

36

5.4

0.21 ± 0.07 bc

36

6.7

0.35 ± 0.09 c

30

9.3

0.79 ± 0.06 d

39
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Figure 4.1 – Rear view of package highlighting the sticky board compartment used to
quantify mite mortality over time.

87

Figure 4.2 – Application of the OA solution using a pressurized airbrush.
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Figure 4.3 – Left: The packages were chilled at 2°C for 20 minutes to force the bees
to cluster. Right: front view of the package highlighting the sliding screened side
used to collect dead adult bees.

Figure 4.4 – Varroa mite mortality response to a 2.8% OA solution when sprayed on package bees.
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Figure 4.5 – Honey bee mortality response to a 2.8% OA solution when sprayed on package bees.
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Chapter 5

Oxalic acid – a prospective tool for reducing Varroa mite populations in package
bees: Part II – Field evaluation

Abstract
Results of research reported in chapter 4 were used to establish an optimum
volume of a 2.8% oxalic acid (OA) solution to spray on package bees to reduce Varroa
mite populations while minimizing adult bee mortality. The two studies described in this
chapter are field trials of package bee treatment protocols. The first (preliminary study)
was a feasibility study conducted prior to the laboratory studies reported in chapter 4.
The second (secondary study) was conducted after the laboratory studies reported in
chapter 4. In both studies I made 2 lb Varroa-infested packages and treated them with
OA prior to installation. OA treatment significantly reduced Varroa infestation when
compared to untreated packages, and OA’s efficacy was dependant on the concentration
and volume applied. The outcome of my research provides beekeepers and package bee
shippers guidance for using OA to reduce mite populations in package bees.

Introduction
Numerous studies have investigated using oxalic acid (OA) to control Varroa
mites in honey bee colonies. In contrast, techniques for treating package bees with OA
have not been previously investigated. In chapter 4, I established an optimum volume of
OA for spraying on package bees to provide effective mite control while minimizing
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adult bee mortality (3.0 mL of a 2.8% OA sugar water solution (sugar:water) (1:1) (w:w)
per 1000 bees). I derived the optimum volume recommendation from a laboratory
experiment where 97 cages containing approximately 1600 adult bees were treated with
OA. The two studies reported in this chapter (chapter 5) comprise the field component of
my research on using OA to reduce Varroa mite populations in package bees. My
laboratory and field studies combine to provide package bee treatment recommendations
that beekeepers or package bee shippers can safely use to reduce Varroa mites in package
bees.
The two experiments reported in this chapter are subsequently referred to as the
preliminary study and the secondary study. The preliminary study was conducted before
the laboratory evaluation described in chapter 4. At the time I conducted the preliminary
study, European and Canadian recommendations for dissolving OA in sugar water to
treat colonies were not established. Most research reviewed by Nanetti et al. (2003) and
Rademacher and Harz (2006) found that a single autumn trickle treatment with 50 mL of
a 3.0% OA sugar water solution (1:1) (w:w) provided an efficacy of greater than 90% in
Central Europe. For my preliminary study, I chose a conservative concentration and
volume of OA for package bee treatment to minimize the risk of adult bee mortality. I
chose to apply 25 mL of a 2.0% OA sugar water solution (sugar:water) (1:1) (w:w) per 2
lb package to approximate a dose that was less than the 48 hour LD10 for adult honey
bees (equivalent to 3.9 mL per 1000 bees) reported in chapter 1. The results of the
preliminary study, 62.5 ± 15.8% Varroa infestation reduction, led me to conduct the
laboratory studies (chapter 4) and subsequent secondary study to find the optimum
volume and concentration of OA to apply to package bees.
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At the time the secondary study was conducted, the Canadian Honey Council had
provided the American Beekeeping Federation their OA registration data packet to
expedite its registration in the United States. As a result, the recommended concentration
of the OA solution that will appear on the United States label will most likely be identical
to the Canadian label. Therefore, I used a concentration of OA for the secondary study
that was based on the Canadian treatment recommendations for honey bee colonies. The
Canadian label recommends dissolving 35 g of OA dihydrate in 1 L of warm syrup made
from a mixture of sugar and water (sugar:water) (1:1) (weight:volume) (Special
Supplement 2005). This mixture results in a 2.8% OA sugar water solution by weight
(sugar:water) (1:1) (w:w). I used my results from chapter 4 regarding the volume of a
2.8% OA solution to apply to packages for > 90% mite control and no significant bee
mortality. The goal of the secondary study was to verify the laboratory-based protocol
for treating package bees with OA to reduce Varroa populations. The end product would
be a field-tested recommendation for treating package bees or bulk bee boxes that would
be useful to beekeepers and package bee shippers.

Materials and Methods
Preliminary study
Stocking of packages
I shook 18 kg of Varroa-infested adult honey bees from 12 source colonies into a
bulk bee box on the evening of May 15th, 2005. The source colonies were located at the
University of Nebraska-Lincoln’s Agricultural Research and Development Center
(ARDC) near Mead, NE. I had previously caged the queens from the source colonies to

94
ensure that all mites were phoretic on adult bees (April 25). The source colonies were 2
stories high and were composed of a mixture of Italian and Carniolan bees. I added 1
frame of honey, 2 frames of pollen and nectar, 1 frame of unsealed brood, and 1 frame
with 20 caged queens to stabilize the bulk bee box. In addition, I fit the bulk bee box
with top feeders that contained 6 L of light syrup (sugar:water) (1:1) (w:w) and 3 L of
water. I maintained the bees in the bulk box overnight to allow the bees to cluster and the
mite population to become equally distributed.
The next day, I made 19 packages of adult bees by subdividing the adult bee
population in the bulk bee box (May 16). The package cages were standard, 2 lb cages
made of pine wood and 8-mesh hardware cloth. They contained a caged queen and a
feeder can containing light syrup (sugar:water) (1:1) (w:w). The average weight of the
adult bees in 8 randomly chosen packages was 1.9 ± 0.2 lbs (0.8 ± 0.1 kg). After
transferring bees from the bulk cage to individual packages, I held them in a dark, cool
warehouse for 72 hours.

Establishing the volume of OA to apply to the packages
I used the bioassay data from chapter 1 to determine a conservative dose of OA to
apply to the packages without injuring adult bees. The bioassay data estimated the 48
hour LD10 for adult honey bees to be 177 µg per bee (95% CL = 120 to 226 µg per bee)
(Table 1.1). I picked a volume of 25 mL of a 2.0% OA sugar water solution
(sugar:water) (1:1) (w:w) per package to approximate a dose that was less than the 48
hour LD10 for adult honey bees (equivalent to 3.9 mL per 1000 bees). A volume greater
than 25 mL may have resulted in the premature death of packages. My calculations were
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as follows: 25 g of OA in 1 L of sugar water results in approximately 0.025 g OA/mL
solution (2.0% OA sugar water solution). 25 mL of OA solution X 0.025 g OA/mL
solution = 0.625 g OA per package (625,000 µg per package). 625,000 µg per package /
6500 bees per package = 96 µg per bee.

Treatment and data collection
I randomly assigned the 19 packages to 2 treatment groups: 1.) untreated and 2.)
OA treatment. I prepared a 2.0% solution of OA by mixing 25 g OA with 1 L of sugar
water (sugar:water) (1:1) (w:w). I administered the treatments by spraying 25 mL of the
OA solution directly on the bees through the mesh screen cage using a non-pressurized
sprayer (spray bottle) 72 hours after the packages were made. I measured 25 mL of the
OA solution in a graduated cylinder, poured the liquid into the spray bottle, and sprayed
the adult bee cluster until the solution was gone. I made an effort to maximize OA
contact with the adult bees by spraying both sides of the screen cages. I sprayed the
untreated group with 25 mL of sugar water (sugar:water) (1:1) (w:w).
I installed the packages in single-story Langstroth beehives (24.4 cm deep hive
body) approximately 8 hours after treatment in an apiary near Lincoln, NE. I furnished
each hive with 8 empty frames with foundation and a division board feeder containing 1
gallon of syrup (sugar:water) (2:1) (w:w). The entrances to the hives were reduced to
approximately 2.5 cm to reduce drifting and discourage robbing behavior. As the
experiment progressed over a 7 week period, the hives were provided with a queen
excluder and 1 or 2 supers (16.8 cm deep) as needed.
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I collected 8 samples of approximately 300 adult bees in alcohol from the bulk
bee box while stocking the packages to estimate the pre-treatment Varroa infestation
level on adult bees. I also collected approximately 300 adult bees in alcohol 1 and 3
weeks after package installation to estimate the post-treatment Varroa infestation level on
adult bees. I estimated the pre- and post-treatment Varroa infestation levels using the
alcohol wash method (Shimanuki and Knox 2000). All mites were phoretic on adult bees
1 week after package installation because appropriately aged brood for mite invasion was
not yet present in the hives. In contrast, the hives had brood of all ages (eggs, larvae, and
pupae) 3 weeks after package installation. I measured the square inches of capped
worker brood and counted the number of frames that the adult bee cluster occupied 3 and
6 weeks after package installation. I weighed the hives at the end of the study to quantify
the impact of OA treatment on weight gain (7 weeks after package installation).

Experimental design and statistical analysis
I designed my experiment as a completely randomized design (CRD). I used
mites-per-100 adult bees 1 and 3 weeks after package installation, the percentage
reduction in Varroa infestation 1 and 3 weeks after package installation, the number of
frames of adult bees in each hive 3 and 6 weeks after package installation, the square
inches of capped worker brood 3 and 6 weeks after package installation, and the average
weight-per-hive 7 weeks after package installation as response variables.
I analyzed the mites-per-100 adult bees data, the percentage reduction in Varroa
infestation data, the number of frames of adult bees data, and the square inches of capped
worker brood data using PROC GLIMMIX (SAS Institute 2006) and separated means
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using a t-test (α = 0.05). I fit a generalized linear model (GLM) for each of the
aforementioned response variables using a normal distribution except for the number of
frames of adult bees data. This data set differed from the other response variables
because the data were frame counts (1 to 9 frames). For this response variable, I fit a
GLM and implemented the Poisson distribution in PROC GLIMMIX.
I framed my data as a factorial with time and treatment as factors. Time had 2
levels: 1 and 3 weeks (or 3 and 6 weeks depending on the response variable). Treatment
had 2 levels: untreated and OA treatment. I applied the ‘group=trt’ option in PROC
GLIMMIX to fit a separate variance for the 2 treatment levels. I used PROC
UNIVARIATE (SAS Institute 2006) to verify my assumptions of normality and equal
variance (except for the number of frames data as this distribution was Poisson).
I also analyzed the average weight-per-hive data using PROC GLIMMIX (SAS
Institute 2006) and separated means using a t-test (α = 0.05). This data set differed from
the abovementioned because it was not a factorial. It was a CRD with two treatments:
untreated and OA treatment.

Secondary study
The materials and methods that I used for the secondary study were identical to
those described for the preliminary study except for the differences listed below:
1. Stocking of packages
a. I shook 29 kg of Varroa-infested adult honey bees from 20 source colonies
into a bulk bee box in September 2006.
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b. I made 31 packages of adult bees by subdividing the adult bee population in
the bulk bee box. Each package was placed on a scale and the scale was
tared. I then stocked the package with adult bees until it weighed 2 lbs. The
average weight of the adult bees present in the packages was 2.0 ± 0.1 lbs (0.9
± 0.03 kg) (n = 31).
2. Establishing the volume of OA to apply to the packages
a. I used my recommendation from chapter 4 regarding the optimum dosage of
OA to apply to packages for > 90% mite control and no significant bee
mortality.
i. The recommended volume that I applied was 3.0 mL of a 2.8% OA
sugar water solution (sugar:water) (1:1) (w:w) per 1000 bees.
ii. I also included a slightly higher dose to monitor the effects on adult
honey bees (4.5 mL of a 2.8% OA sugar water solution (sugar:water)
(1:1) (w:w) per 1000 bees). I chose this dose to assess the risk
associated with over-application.
3. Treatment and data collection
a. I treated the packages the same day that they were stocked with bees.
b. The experiment was terminated 8 days after package installation.
c. I prepared a 2.8% solution of OA by mixing 35 g OA with 1 L of sugar water
(sugar:water) (1:1) (w:w).
d. I administered the treatments using a Solo® backpack sprayer with a 3 gallon
chemical tank and piston pump system. I furnished the sprayer with a
MeterJet™ spray gun. The spray gun was calibrated to deliver either 7.0 or
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10.5 mL of OA solution with each pull of the trigger depending on the
treatment.
i. Three pulls of the trigger with the MeterJet™ spray gun calibrated to
deliver 7.0 mL per pull resulted in 21.0 mL per package (3.0 mL per
1000 bees treatment).
ii. Three pulls of the trigger with the MeterJet™ spray gun calibrated to
deliver 10.5 mL per pull resulted in 31.5 mL per package (4.5 mL per
1000 bees treatment).
e. I collected 10 samples of approximately 300 adult bees in alcohol from the
bulk bee box while stocking the packages to estimate the pre-treatment
Varroa infestation level on adult bees.
4. Experimental design and statistical analysis
a. I did not measure the square inches of capped worker brood or weigh the
hives.
b. I used mites-per-100 adult bees 8 days after package installation, the
percentage reduction in Varroa infestation 8 days after package installation,
and the number of frames of adult bees 8 days after package installation as
response variables.
c. I analyzed the mites-per-100 adult bees data, the percentage reduction in
Varroa infestation data, and the number of frames of adult bees data using
PROC GLIMMIX (SAS Institute 2006), and I separated means using a t-test
(α = 0.05). I fit a GLM for each of the aforementioned response variables
using a normal distribution except for the number of frames of adult bees
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data. This data set differed from the other response variables because the data
were frame counts (1 to 9 frames). For this response variable, I fit a GLM
and implemented the Poisson distribution in PROC GLIMMIX.
i. The mites-per-100 adult bees data were designed as a CRD with 4
treatments: 1.) bulk bee box pre-treatment, 2.) untreated, 3.) 3.0 mL per
1000 bees OA solution, and 4.) 4.5 mL per 1000 bees OA solution.
ii. The percentage reduction in Varroa infestation data and the number of
frames of adult bees data were designed as CRD’s with 3 treatments: 1.)
untreated, 2.) 3.0 mL per 1000 bees OA solution, and 3.) 4.5 mL per
1000 bees OA solution.

Results
Preliminary study
My assumption of normality was met for all response variables for which I fit a
GLM using a normal distribution. These data sets produced a symmetric box-plot and a
straight-lined normal probability plot that confirmed normality. A plot of the residual
versus the predicted values revealed a problem with non-constant variance. The
‘group=trt’ option that I employed in PROC GLIMMIX fixed the non-constant variance
issue. After fitting a separate variance for each treatment, a plot of the residual versus the
predicted values revealed no obvious patterns and was indicative of data that had constant
variance.
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Treatment*time factorial with mites-per-100 adult bees as the response variable
I modeled the factors treatment, time, and the treatment*time interaction. The
treatment*time interaction was significant (F = 7.65, df = 1, 34, P = 0.0091), and
therefore, the simple effects of treatment and time were considered. See Table 5.1 for
the treatment estimates of mites-per-100 adult bees 1 and 3 weeks after package
installation. One week after package installation, hives established from the OA-treated
packages had 5.1 ± 1.7 fewer mites-per-100 bees than hives established from the
untreated packages (t = 3.08, df = 34, P = 0.0041). In contrast, there was no significant
difference in Varroa infestation between hives established from OA-treated packages and
hives established from untreated packages 3 weeks after package installation (t = 0.84, df
= 34, P = 0.4059). When only considering the untreated packages, there were 6.9 ± 1.4
more mites-per-100 bees 1 week after package installation than 3 weeks after package
installation (t = 5.58, df = 34, P = 0.0001). Similarly, when only considering the OAtreated packages, there were 2.2 ± 1.2 more mites-per-100 bees 1 week after package
installation than 3 weeks after package installation (t = 1.87, df = 34, P = 0.0501).
The Varroa infestation in the bulk bee box was not significantly different than the
Varroa infestation in the hives established from untreated packages 1 week posttreatment (t = 0.30, df = 15, P = 0.7693).

Treatment*time factorial with percentage reduction in Varroa infestation as the response
variable
I modeled the factors treatment, time, and the treatment*time interaction. The
treatment*time interaction was significant (F = 7.59, df = 1, 34, P = 0.0094), and
therefore, the simple effects of treatment and time were considered. See Table 5.2 for
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the treatment estimates of the percentage reduction in Varroa infestation 1 and 3 weeks
after package installation. One week after package installation, OA treatment
significantly reduced Varroa infestation by 70.6 ± 23.0% when compared to hives
established from the untreated packages (t = 3.07, df = 34, P = 0.0042). In contrast, there
was no significant difference in Varroa infestation between hives established from OAtreated packages and hives established from untreated packages 3 weeks after package
installation (t = 0.85, df = 34, P = 0.4008). When only considering the untreated
packages, the 3 week Varroa infestation diminished 96.1 ± 17.2% compared to the
Varroa infestation 1 week after package installation (t = 5.58, df = 34, P = 0.0001).
Similarly, when only considering the OA-treated packages, the 3 week Varroa infestation
diminished 30.7 ± 16.3% compared to the Varroa infestation 1 week after package
installation (t = 1.88, df = 34, P = 0.0503).

Treatment*time factorial with the number of frames of adult bees as the response
variable
I modeled the factors treatment, time, and the treatment*time interaction. The
treatment*time interaction was not significant (F = 0.12, df = 1, 34, P = 0.7356), and
therefore, the main effects of treatment and time were considered. The treatment effect
was not significant (F = 0.06, df = 1, 34, P = 0.8096). The time effect was significant (F
= 11.00, df = 1, 34, P = 0.0022). See Table 5.3 for the treatment estimates of the number
of frames of adult bees 3 and 6 weeks after package installation.
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Treatment*time factorial with the square inches of capped worker brood as the response
variable
I modeled the factors treatment, time, and the treatment*time interaction. The
treatment*time interaction was not significant (F = 0.01, df = 1, 34, P = 0.9071), and
therefore, the main effects of treatment and time were considered. The treatment effect
was not significant (F = 0.01, df = 1, 34, P = 0.9321). The time effect was also not
significant (F = 1.26, df = 1, 34, P = 0.2702). See Table 5.4 for the treatment estimates
of the square inches of capped worker brood 3 and 6 weeks after package installation.

CRD with the weight-per-hive (lbs) 7 weeks after package installation as the response
variable
The treatment effect was not significant (F = 1.53, df = 1, 17, P = 0.2334). See
Table 5.5 for the treatment estimates of the weight-per-hive 7 weeks after package
installation.

Secondary study
My assumption of normality was met for the 2 response variables for which I fit a
GLM using a normal distribution. These data sets produced a symmetric box-plot and a
straight-lined normal probability plot that confirmed normality. A plot of the residual
versus the predicted values revealed a problem with non-constant variance. The
‘group=trt’ option that I employed in PROC GLIMMIX fixed the non-constant variance
issue. After fitting a separate variance for each treatment, a plot of the residual versus the
predicted values revealed no obvious patterns and was indicative of data that had constant
variance.
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CRD with mites-per-100 adult bees 8 days after package installation as the response
variable
The treatment effect was significant (F = 121.86, df = 3, 37, P = 0.0001). See
Table 5.6 for the treatment estimates of mites-per-100 adult bees 8 days after package
installation. Colonies established from the untreated packages had 2.2 ± 0.9 more mitesper-100 bees than the bulk bee box (t = 2.36, df = 37, P = 0.0237). Colonies established
from the packages treated with the low OA volume (3.0 mL per 1000 bees) had 7.7 ± 0.7
fewer mites-per-100 bees than the bulk bee box (t = 10.44, df = 37, P = 0.0001).
Similarly, colonies established from the packages treated with the high OA volume (4.5
mL per 1000 bees) had 7.6 ± 0.8 fewer mites-per-100 bees than the bulk bee box (t =
10.06, df = 37, P = 0.0001). Colonies established from the packages treated with the low
OA volume had 9.9 ± 0.6 fewer mites-per-100 bees than the untreated packages (t =
16.25, df = 37, P = 0.0001). Likewise, colonies established from the packages treated
with the high OA volume had 9.7 ± 0.6 fewer mites-per-100 bees than the untreated
packages (t = 15.61, df = 37, P = 0.0001). There was no significant difference in Varroa
infestation between colonies established from the packages that were treated with the low
OA volume and the packages that were treated with the high OA volume (t = 0.50, df =
37, P = 0.6178).
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CRD with the percentage reduction in Varroa infestation 8 days after package
installation as the response variable
The treatment effect was significant (F = 136.95, df = 2, 28, P = 0.0001). See
Table 5.7 for the treatment estimates of the percentage reduction in Varroa infestation 8
days after package installation. Colonies established from the packages treated with the
low OA volume (3.0 mL per 1000 bees) had 104.5 ± 6.4% fewer mites than the colonies
established from the untreated packages (t = 16.25, df = 28, P = 0.0001). Colonies
established from the packages treated with the high OA volume (4.5 mL per 1000 bees)
had 102.8 ± 6.6% fewer mites than the colonies established from the untreated packages
(t = 15.59, df = 28, P = 0.0001). There was no significant difference in Varroa
infestation between colonies established from the packages that were treated with the low
OA volume and the packages that were treated with the high OA volume (t = 0.48, df =
28, P = 0.6349).

CRD with the number of frames of adult bees 8 days after package installation as the
response variable
The treatment effect was not significant (F = 0.08, df = 2, 28, P = 0.9278). See
Table 5.8 for the treatment estimates of the number of frames of adult bees in hives 8
days after package installation.

Discussion
Preliminary study
Oxalic acid treatment significantly reduced Varroa infestation by 71% when
compared to hives stocked with untreated packages one week after installation. Although

106
this statistic is encouraging, the standard error of the estimate was ± 23%. As a result, the
efficacy of OA was highly variable and unreliable. An explanation for the high variance
in efficacy is that the packages may have received different volumes of the OA solution.
It was impossible to deliver exactly 25 mL of the OA solution per package with a nonpressurized spray bottle. Furthermore, I only weighed a subsample of the packages to
estimate the number of adult bees present, resulting in variable dosages. I addressed both
of these issues in the secondary study by using a MeterJet™ spray gun to accurately
apply the OA solution and by weighing each package prior to treatment.
Another drawback of the preliminary study is that I treated the packages the same
day that I installed them. This may have reduced the efficacy of OA against mites
because the length of OA exposure before installation was brief. In contrast, I maximized
exposure time by treating the packages the same day they were made for the secondary
study. This ensured that mites would be exposed to OA for at least 72 h before
installation in hives.
Despite OA’s variable efficacy when applied to package bees in the preliminary
study, treatment did not negatively affect the adult bee population, the amount of capped
worker brood, or the hive weight at the end of the study. Furthermore, all hives remained
queenright throughout experimentation.
I designed the preliminary experiment so that all mites would be phoretic on adult
bees 1 week after package installation. This ensured that the 1 week post-treatment
sample would provide an accurate comparison between the Varroa infestation in the bulk
bee box and the Varroa population in each hive. Furthermore, the 1 week post-treatment
sample verified that the Varroa infestation in the bulk bee box (7.3 ± 1.0 mites-per-100
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bees) was not significantly different than the Varroa infestation in the hives established
from untreated packages (7.8 ± 1.2 mites-per-100 bees). This confirmed that mites had
not invaded brood and that my experimental protocol regarding the use of the bulk bee
box as a pre-treatment estimate of Varroa infestation was justified.
I predicted that the hives would have brood of all ages (eggs, larvae, and pupae) 3
weeks after package installation because the packages were installed with healthy, mated
queens. An interesting result from the preliminary study was that the Varroa infestation
on adult bees significantly declined in all experimental hives 3 weeks after package
installation, regardless of treatment (Tables 5.1 and 5.2). This statistic indicates that
mites readily invade appropriately aged brood to begin reproduction in hives started from
package bees, and highlights the importance of reducing Varroa populations in packages
prior to installation.

Secondary study
An unexpected result from the secondary study was that although no Varroa
reproduction could have occurred, the Varroa infestation in hives established from the
untreated packages significantly increased 8 days after package installation (Table 5.6).
This observation can be explained by the presence of robbing bees during the installation
process. Upon reaching the apiary, the packages were immediately inundated with bees
from an unknown source. The packages had a single layer of bees clinging to the outside
of the cages. I quickly installed the packages because daylight was running out and the
bees had consumed most of the syrup in their feed cans. I released the queens and sealed
the hive entrances to ensure no additional bees could invade the hives. Despite my

108
efforts, some foreign bees entered each hive during installation. The next morning,
robbing bees were no longer a problem and I opened each hive entrance approximately
1.3 cm to allow the bees to fly.
I terminated the secondary study after collecting the samples of adult bees 8 days
after package installation. Although each hive had approximately 2 frames of adult bees,
all hives were queenless. I found 3 dead queens inside of their hives that had battered
wings and were stripped of body hair. The robbing bees must have balled the queens
while the package bees were still wet from the installation process. In hindsight, I should
have left the queens in their cages overnight instead of releasing them into the hives when
foreign bees were present. Regardless, the secondary study provides evidence that
invading bees that drift into or rob a hive have the potential to significantly increase the
Varroa infestation.
It is interesting that the colonies established from the packages treated with the
low or high volume of OA had approximately 100% fewer mites than the colonies
established from the untreated packages (remember that percentage reduction in Varroa
infestation was calculated using the bulk bee box as the pre-treatment sample). This
makes sense considering that the untreated packages increased in Varroa infestation by
about 20% and the treated packages had about an 80% reduction in Varroa infestation
(80% reduction in treated hives compared to a 20% increase in untreated hives = 100%
reduction in Varroa infestation). My results suggest that the treated packages were
nearly devoid of Varroa mites prior to installation, and like the untreated packages,
acquired mites due to the invasion of foreign, mite-infested bees.
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The secondary study was conducted in the fall (September) when strong colonies
are prone to attempt to rob small or weak colonies. I did not anticipate robber bees
because there were no other apiaries in the vicinity, suggesting that the robbing bees
originated from feral colonies or a distant apiary. In reality, beekeepers in temperate
climates normally install package bees in the spring when robbing is less likely to occur.
The problem that occurred with robbing bees in the secondary study caused me to
prematurely terminate the experiment. As a result, it was impossible to collect the same
type of data reported in the preliminary study (3 week adult bee samples, square inches of
capped worker brood, hive weight, and queen survival). Consequently, the data gathered
from the secondary study will not be submitted for publication in a scientific journal, but
was included in the dissertation for completeness.

Overall conclusions
The use of the MeterJet™ for OA application was quick, easy, and accurate. If
beekeepers use my recommendation for treating package bees described in chapter 4, I
strongly suggest the employment of a MeterJet™ spray gun used in conjunction with a
backpack sprayer. Chapters 4 and 5 provide strong evidence that deviations in both the
concentration and volume of the OA solution applied will significantly affect efficacy
and adult bee tolerance. Also, it is important to weigh each package, cage, or bulk bee
box before OA treatment to accurately calculate the volume of OA to apply. The
applicator should emphasize accurate measurements when mixing and applying OA to
package bees to maximize efficacy and minimize adult bee injury.
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My chapter 4 results support applying an optimum volume of 3.0 mL of a 2.8%
OA solution per 1000 bees for effective mite control with minimal adult bee mortality.
The outcome of my field trials suggests that OA can be used safely to reduce mites in
package bees, however, the study should be repeated due to the problem that occurred
with robbing bees during installation.
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Table 5.1 – Preliminary study. Treatment estimates with
mites-per-100 adult bees 1 and 3 weeks after package
installation as the response variable. Estimates with different
letters indicate significant differences (t-test, α = 0.05).
Treatment*

Estimate ± Standard error

n

1 week-untreated

7.8 ± 1.2 a

9

1 week-OA 2.0%**

2.7 ± 1.1 b

10

3 week-untreated

0.9 ± 0.3 c

9

3 week-OA 2.0%**

0.5 ± 0.3 c

10

* The Varroa infestation in the bulk bee box was 7.3 ± 1.0 (n=8)
mites-per-100 bees.
** The packages were sprayed with 3.9 mL per 1000 bees of a 2.0%
OA sugar water solution by weight (sugar:water) (1:1) (w:w).
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Table 5.2 – Preliminary study. Treatment estimates with percentage
reduction in Varroa infestation 1 and 3 weeks after package
installation as the response variable. Estimates with different letters
indicate significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error*

n

1 week-untreated

-8.0 ± 16.7 a

9

1 week-OA 2.0%**

62.5 ± 15.8 b

10

3 week-untreated

88.1 ± 4.4 c

9

3 week-OA 2.0%**

93.2 ± 4.1 c

10

* Percentage reduction in Varroa infestation was calculated using the
mite infestation in the bulk bee box as the pre-treatment baseline
(7.3 ± 1.0 mites-per-100 bees).
** The packages were sprayed with 3.9 mL per 1000 bees of a 2.0%
OA sugar water solution by weight (sugar:water) (1:1) (w:w).
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Table 5.3 – Preliminary study. Average number of frames of adult
bees in hives 3 and 6 weeks after package installation. Estimates
with different letters indicate significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

3 week-untreated

3.3 ± 0.6 a

9

3 week-OA 2.0%*

3.7 ± 0.6 a

10

6 week-untreated

5.9 ± 0.8 b

9

6 week-OA 2.0%*

5.8 ± 0.8 b

10

* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0%
OA sugar water solution by weight (sugar:water) (1:1) (w:w).
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Table 5.4 – Preliminary study. Average square inches of capped
worker brood in hives 3 and 6 weeks after package installation.
Estimates with different letters indicate significant differences (t-test,
α = 0.05).
Treatment

Estimate ± Standard error

n

3 week-untreated

282.0 ± 48.8 a

9

3 week-OA 2.0%*

272.9 ± 40.8 a

10

6 week-untreated

226.4 ± 48.8 a

9

6 week-OA 2.0%*

227.8 ± 40.8 a

10

* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0%
OA sugar water solution by weight (sugar:water) (1:1) (w:w).
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Table 5.5 – Preliminary study. Average weight-per-hive 7 weeks after
package installation. Estimates with different letters indicate significant
differences (t-test, α = 0.05).
Treatment

Estimate (lbs) ± Standard error

n

Untreated

91.3 ± 5.0 a

9

OA 2.0%*

82.9 ± 4.7 a

10

* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0%
OA sugar water solution by weight (sugar:water) (1:1) (w:w).
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Table 5.6 – Secondary study. Treatment estimates with mites-per100 adult bees 8 days after package installation as the response
variable. Estimates with different letters indicate significant
differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

Bulk bee box*

9.4 ± 0.7 a

10

Untreated

11.6 ± 0.6 b

10

3.0 mL per 1000 bees**

1.7 ± 0.2 c

11

4.5 mL per 1000 bees**

1.9 ± 0.2 c

10

* The bulk bee box estimate represents the pre-treatment baseline for
Varroa infestation as the samples were obtained as the packages
were made.
** The packages were sprayed with a 2.8% OA sugar water solution
by weight (sugar:water) (1:1) (w:w).
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Table 5.7 – Secondary study. Treatment estimates with percentage
reduction in Varroa infestation 8 days after package installation as
the response variable. Estimates with different letters indicate
significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error*

n

Untreated

-22.5 ± 6.0 a

10

3.0 mL per 1000 bees**

81.9 ± 2.2 b

11

4.5 mL per 1000 bees**

80.3 ± 2.6 b

10

* Percentage reduction in Varroa infestation was calculated using the
mite infestation in the bulk bee box as the pre-treatment baseline
(9.4 ± 0.7 mites-per-100 bees).
** The packages were sprayed with a 2.8% OA sugar water solution
by weight (sugar:water) (1:1) (w:w).
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Table 5.8 – Secondary study. Average number of frames of adult bees
in hives 8 days after package installation. Estimates with different
letters indicate significant differences (t-test, α = 0.05).
Treatment

Estimate ± Standard error

n

Untreated

1.9 ± 0.2 a

10

3.0 mL per 1000 bees*

1.8 ± 0.3 a

11

4.5 mL per 1000 bees*

2.0 ± 0.2 a

10

* The packages were sprayed with a 2.8% OA sugar water solution
by weight (sugar:water) (1:1) (w:w).
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Chapter 6

Bee-to-bee contact drives oxalic acid distribution in honey bee colonies

Abstract
I constructed 10 divided hives to study the distribution of oxalic acid (OA). I split
experimental colonies into 2 equal sections with 1 of 3 divider types. The first divider
allowed trophallaxis to occur between adult bees on each side, but did not allow physical
contact. The second divider did not allow trophallaxis or physical contact. The third
divider allowed both physical contact and trophallaxis between the 2 sides. All 3 dividers
allowed gas exchange of volatile materials. The objective was to investigate factors that
contribute to the distribution of OA in a hive by monitoring Varroa mortality. I trickled
40 mL of a 3.5% OA sugar water solution on one side of the divider. I used sticky boards
to quantify mite fall before, during, and after OA treatment on both treated and untreated
sides. Trophallactic interactions and fumigation did not significantly influence the
distribution of OA. Bee-to-bee contact was the primary route for OA distribution.

Introduction
The bioassay data from chapter 1 indicate that OA has a high acute toxicity to
Varroa mites. I hypothesize that OA may kill Varroa mites via contact. The 24 hour
LC50 (95% CL) for phoretic Varroa mites was 5.12 (3.5 to 7.0) μg of OA per 20-mL vial.
The toxicity of OA to Varroa mites collected from bee brood was quantified by Milani
(2001) who reported that the 24 hour LD50 (95% CL) (median lethal density) for Varroa
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mites collected from brood was 1.9 (1.49 to 2.36) μg/cm2. My bioassay results from
chapter 1 and results from Milani (2001) suggest that OA has a high acute toxicity to
mites. The high acute toxicity of OA to Varroa mites in glass-vial residual bioassays
suggests that OA readily kills mites that come in physical contact with the crystals
although some mite mortality could have been caused by exposure to OA vapors within
the scintillation vials.
The objective of the current study was to identify factors that contribute to the
distribution of OA in a hive and to test my hypothesis that OA kills mites via contact. I
evaluated the importance of fumigation, trophallaxis, and direct contact when trickling
OA. The results will give beekeepers and researchers insight as to how OA is distributed
in hives. My results will provide guidance for selecting application techniques that
maximize the efficacy of OA.

Materials and Methods
Construction of divided (split-unit) hives
I designed and built 10 divided single-story Langstroth hives in June, 2005. My
hives resembled standard, single story Langstroth beehives. I modified the boxes by
splitting them into 2 equal sections that held 4 frames each (Figure 6.1). I separated the
sections using 1 of 3 different dividers. All dividers had a 2 X 46.5 cm wooden frame
that formed bee-tight seals between the sides of the hive body, the inner cover, and the
bottom board. The first divider (single-screen divider) had a 585 cm2 area in its center
made from 8-mesh screen and it allowed trophallaxis and gas exchange between bees on
the 2 sides. The second divider (double-screen divider) had a 585 cm2 area in its center
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made from 2 pieces of 8-mesh screen that were separated by a 2 cm gap. It allowed gas
exchange, but did not allow trophallaxis between the 2 sides. The third divider (queen
excluder divider) had a 585 cm2 area in its center made from plastic queen excluder that
allowed worker bees to move freely between the 2 sides. It allowed trophallaxis, gas
exchange, and physical contact between the 2 sides. The 3 dividers described above are
shown in Figure 6.2. The fourth divider was a solid-wood divider that did not allow adult
bee interaction or gas exchange between the 2 sides.
All divided colonies had a separate entrance for each side. The entrances faced
opposing directions to minimize the drift of adult bees from side-to-side. In addition, the
bottom board was fitted with 8-mesh screen that allowed mites to fall onto a sticky board
placed below the screen. This allowed me to independently monitor mite fall on each
side of the divider (Figure 6.1).
I designed the divided hives to allow me to examine the distribution of OA by
treating one side and monitoring the resulting mite fall in both the treated and untreated
sections. I expected similar mite fall on the sides that were treated with OA regardless of
divider. My intention was to correlate mite fall on the untreated section with divider
type. The design of my dividers allowed me to restrict the amount of adult bee
interaction between each half-unit and ranged from complete isolation (solid divider) to
minimal isolation (queen excluder divider) as described above.

Stocking of hives
I stocked the 10 divided hives by splitting Varroa-infested colonies from an
apiary located at the University of Nebraska Agricultural Research and Development
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Center on June 29, 2005. The apiary was composed of a mixture of Carniolan and Italian
honey bees (Apis mellifera). At this time, all hives were given a solid-wood divider. I
furnished each side of the divided hive with a frame of capped brood, a frame of honey, a
frame of pollen, and an empty frame with foundation. This resulted in 4 frames for each
side and 8 frames for the entire divided Langstroth hive. I transferred adult bees to the
units directly on the combs from which the splits were made. I immediately sealed the
hives and moved them approximately 35 miles to the University of Nebraska-Lincoln
East Campus. I placed a 15 day old queen cell in each side of the divided colonies the
following day (June 30). I left the hives untouched for approximately 2 weeks. This
period allowed mites to emerge from brood cells and gave the virgin queens time to mate
and begin laying eggs.
I randomly assigned 9 of the 10 hives to 3 treatment groups. I assigned 3 hives to
each of 3 treatment groups (single-screen divider, double-screen divider, and queen
excluder divider). I removed the solid-wood dividers that I used when the units were
stocked and replaced them with the appropriate dividers listed above. I also verified that
each side of the divided colony was queenright and that sealed brood was not present. I
only included divided hives that had successfully reared a queen on each side in this
experiment. I used queen cells to make each side queenright resulting in hives void of
capped brood during treatment. This ensured that all mites present in the hives were
phoretic on adult bees and vulnerable to OA treatment.
I left the remaining 10th hive untouched with its solid-wood divider in place. I did
not include the solid-wood divider hive in the statistical analysis of the experiment. I
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used this hive as a control colony to monitor natural mite fall. Prior to experimentation, I
placed sticky boards in all hives for a 48 h period to monitor natural mite fall (July 13).

Treatment and data collection
I replaced the sticky boards prior to OA application (July 15). I treated one side
of the 10 divided hives with 40 mL of a 3.5% OA sugar water solution (sugar:water)
(1:1) (w:w). I trickled the OA solution from above the frames between each occupied
bee-way using a 100 mL syringe and made an effort to maximize contact with the adult
bee population. I chose this dose based on a review article for treating colonies with
minimal capped brood (Rademacher and Harz 2006).
I replaced the sticky boards and counted mite fall at 2, 4, and 6 days posttreatment (July 17, 19, and 21). I placed a Checkmite® strip in each half-hive to quantify
remaining mites (July 21) (the experimental mite population had not previously exhibited
coumaphos resistance). I replaced sticky boards every 48 hours until no mites were
detectable (July 23 and 25). The use of the Checkmite® strips allowed me to quantify the
total number of mites in each hive prior to OA application. I added the total number of
mites recovered 2, 4, and 6 days after OA treatment to the number of mites recovered
after placing Checkmite® strips in the hives. This enabled me to calculate the posttreatment percentage mite fall at 2, 4, and 6 days.

Replication
I replicated the entire experiment to increase the power of my tests (September
2005). The materials and methods were similar to those listed above. The only
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difference was that I did not add queen cells to the hives. Instead, I allowed the bees to
rear a queen from a small patch of eggs that I deliberately left when stocking the units.
Like adding queen cells, allowing the units to rear their own queen ensured that the hives
would be void of capped brood during experimentation.

Experimental design and statistical analysis
I designed my experiment as a split-plot design. The whole plot factor was
divider type (single-screen, double-screen, and queen excluder) and the whole plot unit
was the entire hive. The split-plot factor was treatment with OA (treated and untreated)
and the split-plot unit was a half hive. I used the percentage reduction in Varroa
infestation 2, 4, and 6 days post-treatment as my response variable. I blocked by the
month in which the experiment was conducted (July and September) to account for
variance in the total mite infestation between the two replicates.
I analyzed the data using PROC MIXED (SAS Institute 2006) and I separated
means using a t-test (α = 0.05). I assumed random blocks, although the assumption of
fixed blocks did not change the results. I used the Kenwood-Rogers degrees of freedom
adjustment. I used PROC UNIVARIATE and PROC GPLOT (SAS Institute 2006) to
verify my assumptions of normality and constant variance.

Results
Forty eight hour pre-treatment mite fall
The 48 h pre-treatment mite fall was 30.4 ± 4.0 mites per split-unit hive in the
July replicate (n = 20) and 45.8 ± 6.9 mites per split-unit hive in the September replicate
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(n = 20). The pre-treatment mite fall was not significantly different for the sides
scheduled to receive OA versus the sides scheduled to be left untreated for either
replicate (t = 0.25, df = 36, P = 0.8048).

Total mite infestation
The total number of mites recovered per split-unit hive was 389 ± 52 mites (n =
18) for the July replicate. The total number of mites recovered per split-unit hive was
665 ± 52 mites (n = 18) for the September replicate. The total Varroa infestation in the
September replicate was 276 ± 73 mites greater per split-unit hive than the July replicate
(t = 3.76, df = 34, P = 0.0006).

Randomized Complete Block Design (RCBD) split-plot in time
My assumptions of normality and constant variance were met. I used the ShapiroWilk test in the UNIVARIATE procedure of SAS to verify normality. The Shapiro-Wilk
test indicated that my data were normal (P = 0.5722). In addition, a symmetric box-plot
and a straight-lined normal probability plot confirmed normality. A plot of the residual
versus the predicted values revealed no obvious patterns and was indicative of data that
had constant variance.
In total, there were 18 split-unit hives that were sampled at 2, 4, and 6 days posttreatment (54 observations per replicate). Fifty-four observations in the July replicate
plus 54 observations in the September replicate sum to 108 total observations. The
response variable was percentage reduction in Varroa infestation. See Table 6.1 for a
summary of the F tests for the RCBD split-plot in time effects.
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There was significant divider*treatment interaction (P = 0.0001). The factor
‘time’ was not part of this interaction so I analyzed the main effect for time. The time
effect was significant (P = 0.0001). There was a 43.1 ± 3.6% (n = 36), 51.4 ± 3.6% (n =
36) and 58.5 ± 3.6% (n = 36) reduction in Varroa infestation at 2, 4, and 6 days after OA
application. The above means represent the average mite fall per split-unit hive
regardless of divider type or treatment.
Significantly more mites fell by day 6 than by days 2 or 4. Explicitly, 8.4 ± 1.8%
more mites fell by day 4 versus day 2 (t = 4.73, df = 75, P = 0.0001), 7.1 ± 1.8% more
mites fell by day 6 versus day 4 (t = 3.98, df = 75, P = 0.0001), and 15.4 ± 1.8% more
mites fell by day six versus day 2 (t = 8.71, df = 75, P = 0.0001).

RCBD split-plot on 6 day percentage mite fall
The analysis of the RCBD split-plot in time confirmed that it was appropriate to
only model the 6 day percentage mite fall because more mites fell by day 6 than days 2
and 4. To simplify my model, I removed the time factor and used 6 day percentage mite
fall as the sole response variable in my subsequent data analysis. This reduced the total
number of observations from 108 to 36 (108 total observations / 3 time intervals = 36
observations for 6 day percentage mite fall). See Table 6.2 for a summary of the F tests
for the RCBD split-plot on 6 day percentage mite fall.
There was significant divider*treatment interaction (P = 0.0001). I did not
consider the main effects of divider and treatment because of the significant interaction
term. Rather, I analyzed the simple effects to draw conclusions about these two factors.
Table 6.3 is a summary of the 6 treatment means reported as percentage reduction in
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Varroa infestation. Treatment combinations in the divider/treatment column with ‘OA
treated side’ indicate that OA was applied. Treatment combinations in the
divider/treatment column with ‘untreated side’ indicate that OA was not applied. For
example, the 6 divided hives with a single-screen divider averaged 73.3 ± 7.5% mite
reduction on the side that was treated with OA and 22.6 ± 7.5% mite reduction on the
side that was left untreated.
The sides that were treated with OA had significantly more mite fall than the
untreated sides for all 3 dividers. When only considering the units with single-screen
divider, sides that were treated with OA had 50.7 ± 5.4% greater mite fall than the sides
left untreated (t = 9.33, df = 15, P = 0.0001). When only considering the units with
double-screen divider, sides that were treated with OA had 59.6 ± 5.4% greater mite fall
than the sides left untreated (t = 10.96, df = 15, P = 0.0001). When only considering the
units with queen excluder divider, sides that were treated with OA had 15.9 ± 5.4%
greater mite fall than the sides left untreated (t = 2.92, df = 15, P = 0.0105).
There was no difference in the percentage mite fall on the sides that were treated
with OA for all three dividers. When only considering the sides that were treated with
OA; units with double-screen dividers had 4.4 ± 7.8% greater mite fall than units with
queen excluder dividers (t = 0.55, df = 22.2, P = 0.5849), units with double-screen
dividers had 11.5 ± 7.8% greater mite fall than units with single-screen dividers (t = 1.46,
df = 22.2, P = 0.1579), and units with queen excluder dividers had 7.1 ± 7.8% greater
mite fall than units with single-screen dividers (t = 0.91, df = 22.2, P = 0.3742).
When only considering the untreated sides, units with the queen excluder divider
had significantly more mite fall than units containing either single- or double-screen
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dividers. When only considering the untreated sides, units with the queen excluder
divider had 39.3 ± 7.8% greater mite fall than units containing double-screen dividers (t =
5.01, df = 22.2, P = 0.0001) and units with the queen excluder divider had 42.0 ± 7.8%
greater mite fall than units containing single-screen dividers (t = 5.35, df = 22.2, P =
0.0001). The percentage mite fall on the untreated sides was not significantly different
for units containing the single-screen versus the double-screen dividers (t = 0.34, df =
22.2, P = 0.7403).

Discussion
I accept my hypothesis that OA kills mites via contact. Only the queen excluder
divider permitted worker bees to move freely and allowed physical contact between the 2
sides. As Table 6.3 illustrates, bee-to-bee contact was the primary route for OA
distribution because divided hives with queen excluders had significantly more mite fall
(65%) on their untreated sides than divided hives with single-screen or double-screen
dividers.
As expected, the percentage mite reduction was not significantly different on the
sides of the divided hives that were treated with OA regardless of divider type. My
intention was to correlate mite fall on the untreated side with divider type. Divided hives
with single-screen and double-screen dividers averaged 23 and 25% mite fall on their
untreated sides after 6 days, respectively. The 2 control colonies with solid-wood
dividers (one control per replicate) averaged 29% (n = 2) mite fall on their untreated sides
after 6 days. The 29% mite fall on the untreated sides of the control colonies containing
solid-wood dividers corresponds with the mite fall on the untreated sides of the single-
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screen and double-screen divided hives (23 and 25%). Trophallactic interactions and
fumigation did not significantly influence the distribution of OA as single-screen, doublescreen, and solid wood divided hives had similar mite fall on their untreated sides.
Significantly more mites fell 6 days after OA application than 2 or 4 days after
OA application. This statistic may be interpreted several ways. One interpretation is that
OA has residual activity against Varroa for at least 6 days post-treatment. Another
interpretation is that a portion of the Varroa mites exposed to OA experience a drawn-out
death. My data from chapter 1 and Milani (2001) demonstrate that OA has a high acute
toxicity to mites in laboratory bioassays 24 hours post-treatment. Chapter 1 and Milani
(2001) do not quantify the chronic toxicity of OA to Varroa because of the impossibility
of sustaining mite populations for long periods of time away from their honey bee hosts.
Perhaps the chronic toxicity of OA for phoretic mites in the hive environment is
significantly less than the acute toxicity reported in chapter 1 and Milani (2001).
One important assumption of my experiment was that the single-screen divider
allowed trophallaxis to occur between adult bees on each side. This assumption held true
throughout experimentation as I observed adult bees performing proboscis extensions and
trophallactically interacting between the single-screen dividers. The role of trophallaxis
in the distribution of Perizin (coumaphos) in honey bee colonies was investigated by van
Buren et al. (1992) who divided hives into 3 compartments with screens and traced the
amount of coumaphos transferred between the sections via trophallaxis. Although
trophallactic interactions were of minor importance in the distribution of coumaphos, the
authors indicate that trophallaxis was occurring between the screened sections of the
hive.
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Anecdotal observations from beekeepers suggest that adult honey bees will ingest
sugar water feed containing OA. I noticed small, pea-size pools of the OA sugar water
solution on the top bars of several hives up to 6 days after OA application. I did not
observe ingestion of the OA solution by adult bees and the pools eventually evaporated.
If the anecdotal observation that bees will ingest sugar water containing OA is true, my
results suggest that the concentration must be lower than 3.5% OA by weight. My results
only apply to the trickle method with a 3.5% OA sugar water solution (1:1) (w:w). The
distribution of OA in honey bee colonies when the vaporizer method is used was not
tested in my study. My results give beekeepers and researchers insight as to how OA is
distributed in hives and provide guidance for selecting application techniques that
maximize the efficacy of OA.

131
Table 6.1 – F tests for RCBD split-plot in time.
Effect

Numerator Denominator
df
df

F

P

divider

2

14

5.9

0.0142

treatment

1

75

853.8

0.0001

divider*treatment

2

75

75.8

0.0001

time

2

75

38.1

0.0001

divider*time

4

75

0.9

0.4567

treatment*time

2

75

0.1

0.8994

divider*treatment*time

4

75

0.2

0.9341
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Table 6.2 – F tests for RCBD split-plot on 6 day percentage mite fall.
Effect

Numerator Denominator
df
df

F

P

divider

2

14

6.8

0.0086

treatment

1

15

179.6

0.0001

divider*treatment

2

15

18.0

0.0001
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Table 6.3 – Percentage reduction in Varroa infestation 6 days posttreatment. Estimates with different letters indicate significant
differences (t-test, α = 0.05).
Divider type / Treatment

Estimate ±
Standard Error

n

single screen / oa* treated side

73.3 ± 7.5 a

6

double screen / oa treated side

84.8 ± 7.5 a

6

queen excluder / oa treated side

80.5 ± 7.5 a

6

single screen / untreated side

22.6 ± 7.5 b

6

double screen / untreated side

25.2 ± 7.5 b

6

queen excluder / untreated side

64.6 ± 7.5 c

6

* oxalic acid
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Figure 6.1 – Left: split-unit Langstroth hive with single-screen divider. Right: screened
bottom board with opposing entrances.
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Figure 6.2 – Left to right: double screen divider and queen excluder divider.

136
References Cited
Ali, M.A., M.D. Ellis, J.R. Coats, and J. Grodnitzky. 2002. Laboratory evaluation of 17
monoterpenoids and field evaluation of two monoterpenoids and two registered
acaricides for the control of Varroa destructor Anderson & Trueman (Acari:
Varroidae). American Bee Journal 142(1): 50-53.
Ali, M.A., and M.D. Ellis. 2000. The effect of Varroa mite infestation level on
wintering honey bee colonies in the north central region of the U.S. Proceedings of
the American Bee Research Conference 140(11): 901.
Aliano, N.P., and M.D. Ellis. 2005a. A strategy for using powdered sugar to reduce
varroa populations in honey bee colonies. Journal of Apicultural Research 44(2): 5457.
Aliano, N.P., and M.D. Ellis. 2005b. Only large amounts of powdered sugar applied
directly to brood cells harms immature honey bees. Journal of Apicultural Research
44(1): 33-35.
Anonymous. 1987. Varroa mites found in the United States. American Bee Journal
127(11): 745-746.
Anderson, D., and J.W.H. Trueman. 2000. Varroa jacobsoni (Acari: Varroidae) is
more than one species. Experimental and Applied Acarology 24: 165-189.
Ball, B.V. 1994. Host-parasite-pathogen interactions. In A. Matheson [ed.], New
perspectives on Varroa. IBRA, Cardiff, UK. p. 5-11.
Beetsma, J. 1994. The Varroa mite, a devastating parasite of Western honey bees and an
economical threat to beekeeping. Outlook Agriculture 23: 169-175.
Boecking, O., K.S. Woo, and W. Ritter. 1998. Introduction to Varroa disease. In M.
Matsuka, L.R. Verma, S. Wongsiri, K.K. Shrestha, and U. Partap [ed.] Asian Bees
and Beekeeping: Progress of Research and Development. Science Publishers, Inc.,
Enfield, New Hampshire. pp. 64-66.
Boot, W.J., N.Q. Tan, P.C. Dien, L.V. Huan, N.V. Dung, L.T. Long, and J. Beetsma.
1997. Reproductive success of Varroa jacobsoni in brood of its original host, Apis
cerana, in comparison to that of its new host, A. mellifera (Hymenoptera: Apidae).
Bulletin of Entomological Research 87: 119-126.
Boot, W.J., J. Beetsma, and J.N.M. Calis. 1994. Behavior of Varroa mites invading honey
bee brood cells. Experimental and Applied Acarology 18: 371-379.

137
Boot, W.J., J.N.M. Calis, and J. Beetsma. 1992. Differential periods of Varroa mite
invasion into worker and drone cells of honey bees. Experimental and Applied
Acarology 16: 295-301.
Büchler, R. 2002. Winterbehandlungsmethoden im Test. Auswirkungen auf die
Volksentwicklung. Allg. Dtsch. Imkerztg. 11: 10-13.
Büchler, R. 1994. Varroa tolerance in honey bees – occurrence characters and breeding.
Bee World 75: 54-70.
Calderone, N.W. 2000. Effective fall treatment of Varroa jacobsoni (Acari:
Varroidae) with a new formulation of formic acid in colonies of Apis mellifera
(Hymenopter: Apidae) in the Northeastern United States. Journal of Economic
Entomology 93(4): 1065-1075.
Cakmak, I., L. Aydin, S. Camazine, and H. Wells. 2002. Pollen traps and walnut-leaf
smoke for Varroa control. American Bee Journal 142(5): 367-370.
Charrière, J., A. Imdorf, and R. Kuhn. 2004. Bienenverträglichkeit von
Varroabehandlungen im Winter. Schweiz. Bienen-Ztg. 4: 19-23.
Charrière, J., and A. Imdorf. 2002. Oxalic acid treatment by trickling against Varroa
destructor: recommendations for use in central Europe and under temperate climate
conditions. Bee World 83(2): 51-60.
Charrière, J.D. 2001. Optimisation of the oxalic acid trickling method and bee tolerability
of different winter treatments: trials in Liebefeld during the last 3 years, Meeting of
the European Group for Integrated Varroa Control, York
(http://www.culturaapicola.com.ar/apuntes/sanidad/07_san_oxalico_optimizacion.pdf
). Accessed November 7, 2007.
Cox-Foster et al. 2007. A metagenomic survey of microbes in honey bee colony collapse
disorder. Sciencexpress (http://www.sciencemag.org/cgi/content/abstract/1146498).
Accessed September 11, 2007.
Creger, T. 2007. Nebraska Department of Agriculture. Telephone conversation on
December 27, 2007. 402-471-6882
de Guzman, L.I., T.E. Rinderer, and L.D. Beaman. 1993. Longevity of Varroa jacobsoni
away from a living host. In L.J. Connor, T. Rinderer, H.A. Sylvester, and S. Wongsiri
[ed.] Asian Apiculture. Wicwas Press, Connecticut, USA, 343-441.
De Jong, D. 1990. Mites: Varroa and other parasites of brood. In R.A. Morse, and R.
Nowogrodzki [ed.] Honey Bee Pests, Predators, and Diseases, 2nd edn. Cornell
University Press, Ithaca, NY, 201-218.

138
De Jong, D., and R.A. Morse. 1988. Utilization of raised brood cells of the honey bee,
Apis mellifera (Hymenoptera: Apidae), by the bee mite Varroa jacobsoni (Acarina:
Varroidae). Entomologia Generalis 14(2): 103-106.
De Jong, D. 1984. Current knowledge and open questions concerning reproduction in the
honey bee mite Varroa jacobsoni. In W. Engels et al. [ed.] Advances in Invertebrate
Reproduction 3. Elsevier Science Publishers B.V., Amsterdam, The Netherlands. pp.
547-552.
De Jong, D., R.A. Morse, and G.C. Eickwort. 1982. Mite pests of honey bees. Annual
Review of Entomology 27: 229-252.
Delaplane, K.S. 1998. Varroa control: timing is everything. American Bee Journal
138(8): 575-576.
Delaplane, K.S., and W.M. Hood. 1997. Effects of delayed acaricide treatment in honey
bee colonies parasitized by Varroa jacobsoni and a late season threshold for the
Southeastern USA. Journal of Apicultural Research 33: 155-159.
Delfinado-Baker, M. 1988. Variability and biotypes of Varroa jacobsoni Oudemans.
American Bee Journal 128(8): 567-568.
Eischen, F. 1998. Varroa’s response to fluvalinate in the Western U.S. American Bee
Journal 138(6): 439-440.
Eischen, F. 1995. Varroa resistance to fluvalinate. American Bee Journal. 135(12): 815816.
Ellis, M.D. 2001. Chemical Control of Varroa Mites. In T.C. Webster and K.S. Delaplane
[ed.], Mites of the honey bee. Dadant and Sons, Inc., Hamilton IL, 179-196.
Ellis, M., R. Nelson, and C. Simons. 1988. A comparison of the fluvalinate and ether roll
methods of sampling for Varroa mites in honey bee colonies. American Bee Journal
128(4): 262-264.
Elzen, P.J., and D. Westervelt. 2002. Detection of coumaphos resistance in Varroa
destructor in Florida. American Bee Journal 142(4): 291-292.
Elzen, P.J., F.A. Eischen, J.R. Baxter, G.W. Elzen, and W.T. Wilson. 1999. Detection of
resistance in US Varroa jacobsoni Oud. (Mesostigmata: Varroidae) to the acaricide
fluvalinate. Apidologie 30: 13-17.
Elzen, P.J., F.A. Eischen, J.B. Baxter, J. Pettis, G.W. Elzen, and W.T. Wilson. 1998.
Fluvalinate resistance in Varroa jacobsoni from several geographic locations.
Apicultural Research 138(9): 674-676.

139
EMEA (The European Agency for the Evaluation of Medicinal Products). 2004.
Committee for veterinary medicinal products: oxalic acid summary report
(http://www.emea.europa.eu/pdfs/vet/mrls/089103en.pdf). Accessed September 21,
2007.
Fakhimzadeh, K. 2001a. Acute impact on the honey bee (Apis mellifera) after treatment
with powdered sugar and CO2 for the control of Varroa destructor. American Bee
Journal 141(11): 817-820.
Fakhimzadeh, K. 2001b. The effects of powdered sugar Varroa control treatments on
Apis mellifera colony development. Journal of Apicultural Research 40(3-4): 105109.
Fakhimzadeh, K. 2000. Potential of super-fine ground, plain white sugar dusting as an
ecological tool for the control of varroasis in the honey bee (Apis mellifera).
American Bee Journal 140(6): 487-490.
Faucon, J.P., P. Drajnudel, and C. Fleche. 1995. Decrease in Apistan efficacy used
against varroasis in the honey bee (Apis mellifera). Apidologie 26(4): 291-296.
Finney, D. J. 1971. Probit analysis. Cambridge University Press, London, England.
Fries, I. 2007. Is the total amount or the concentration of oxalic acid critical for efficacy
in varroa mite control? Agroscope Liebefeld-Posieux Research Station ALP
(http://www.culturaapicola.com.ar/apuntes/sanidad/08_san_oxalico_concentracion.pd
f). Accessed September 24, 2007.
Fries, I. 1993. Varroa biology: a brief review. In A. Matheson [ed.], Living with Varroa.
IBRA, Cardiff, UK. pp. 3-7.
Fuchs, S. 1990. Preference for drone brood cells by Varroa jacobsoni Oud. in colonies of
Apis mellifera carnica. Apidologie 21(3): 193-199.
Gregorc, A., and I. Planinc. 2001. Acaricidal effect of oxalic acid in honeybee (Apis
mellifera) colonies. Apidologie 32: 333-340.
Harbo, J.R., and J.W. Harris. 2001. Resistance to Varroa destructor (Mesostigmata:
Varroidae) when mite – resistant queen honey bees (Hymenoptera: Apidae) were
free-mated with unselected drones. Journal of Economic Entomology 94(6): 13191323.
Harbo, J.R., and J.W. Harris. 1999. Heritability in honey bees (Hymenoptera: Apidae) of
characteristics associated with resistance to Varroa jacobsoni (Mesostigmata:
Varroidae). Journal of Economic Entomology 92(2): 261-265.

140
Harbo, J.R., and R.A. Hoopingarner. 1997. Honey bees (Hymenoptera: Apidae) in the
United States that express resistance to Varroa jacobsoni (Mesostigmata: Varroidae).
Journal of Economic Entomology 90(4): 893-898.
Harris, J.W. 2007. Varroa-sensitive hygiene and recapped brood cells. American Bee
Research Conference Proceedings. American Bee Journal 147(5): 440.
Hoff, F.L., and L.S. Willett. 1994. The U.S. beekeeping industry. USDA agricultural
economic report number 680.
Huang, Z. 2001. Mite zapper – a new and effective method for Varroa mite control.
American Bee Journal 141(10): 730-732.
Hung, A.C.F., J.R. Adams, and H. Shimanuki. 1995. Bee parasitic mite syndrome (II):
the role of Varroa mites and viruses. American Bee Journal 135(10): 702-704.
Ibrahim, A., and M. Spivak. 2005. The relationship between hygienic behavior and
suppression of mite reproduction as honey bee (Apis mellifera) mechanisms of
resistance to Varroa destructor. Apidologie 37: 31-40.
Ifantidis, M.D. 1983. Ontogenesis of the mite Varroa jacobsoni in worker and drone
honey bee brood cells. Journal of Apicultural Research 22(3): 200-206.
Imdorf, A., J. Charrière, and P. Rosenkranz. 1999. Varroa control with formic acid.
Coordination in Europe of research on integrated control of Varroa mites in honey
bee colonies, Agriculture Research Centre, Merelbeke, Belgium, Commission of the
European Communities. pp. 18-26.
Imdorf, A., J. Charrière, V. Kilchenmann, B. Bachofen, S. Bogdanov, and P. Fluri. 1998.
Wie Können dir resistenten Varroa-Milben unter der Schadenschwelle gehalten
werden? Forschungsanstalt für Milchwirtschaft (FAM) Sektion Bienen, Liebefeld,
Schweiz. Mitteilung der Sektion Bienen.
Imdorf, A., S. Bogdanov, V. Kilchenmann, and C. Maquelin. 1995. Apilife VAR: a new
varroacide with thymol as the main ingredient. Bee World 76(2): 77-83.
Imdorf, A., J. Charrière, and B. Bachofen. 1995. Wann ist die Oxalsäure als Varroazid
geeignet? Schweiz. Bienen-Ztg. 7: 389-391.
Imdorf, A., S. Bogdanov, V. Kilchenmann, and C. Maquelin. 1994. Apilife-VAR: a
Varroa treatment substance with thymol as the active ingredient. Schweizerische
Bienen-Zeitung 117(6): 326-333.
Kraus, B., and R.E. Page. 1995. Effect of Varroa jacobsoni (Mesostigmata : Varroidae)
on feral Apis mellifera (Hymenoptera : Apidae) in California. Environmental
Entomology 24(6): 1473-1480.

141

Le Conte, Y., G. Arnold, J. Trouiller, C. Masson, B. Chappe, and G. Ourisson. 1989.
Attraction of the parasitic mite Varroa to the drone larvae of honey bees by simple
aliphatic esters. Science 245: 638-639.
LeOra Software. 1991. POLO-PC: A user’s guide to probit or logit analysis. LeOra
Software, Berkley, CA.
Libert, B., and V.R. Franceschi. 1987. Oxalate in crop plants. Journal of Agriculture and
Food Chemistry 35: 926-938.
Liebig, G. 1998. Zur Eignung des Aufräufelns von Oxalsäure für die Varroabehandlung.
Dtsch. Bienenj 6: 4-6.
Lindberg, C.M., A.P. Melathopoulos, and M.L. Winston. 2000. Laboratory evaluation of
miticides to control Varroa jacobsoni (Acari: Varroidae), a honey bee (Hymenoptera:
Apidae) parasite. Journal of Economic Entomology 93(2): 189-198.
Lodesani, M. 1996. Variabilità dell’ efficacia terapeutica ottenuta con trattamento di
Perizin. L’ape Nostra Amica 18(5): 5-9.
Lodesani, M., M. Colombo, and M. Spreafico. 1995. Ineffectiveness of Apistan®
treatment against the mite Varroa jacobsoni Oud. in several districts of Lombardy
(Italy). Apidologie 26(1): 67.
Macedo, P.A., M.D. Ellis, and B.D. Siegfried. 2002a. Detection and quantification of
fluvalinate resistance in Varroa mites in Nebraska. American Bee Journal 142(7):
523-526.
Macedo, P.A., J. Wu, and M.D. Ellis. 2002b. Using inert dusts to detect and assess
Varroa infestations in honey bee colonies. Journal of Apicultural Research 40(1-2):
3-7.
Macedo, P.A., and M.D. Ellis. 2001. Using the sugar roll technique to detect Varroa
mites in honey bee colonies. University of Nebraska, NebGuide
(http://www.ianr.unl.edu/pubs/insects/g1430.htm). Accessed September 11, 2007.
Macedo, P.A., and M.D. Ellis. 2000. Detecting and assessing Varroa mite infestation by
using powdered sugar to dislodge mites. American Bee Journal 140(11): 906.
Martin, S.J. 2001. The role of Varroa and viral pathogens in the collapse of honey bee
colonies: a modeling approach. Journal of Applied Ecology 38: 1082-1093.
Martin, S.J. 1998. A population dynamic model of the mite Varroa jacobsoni. Ecological
Modelling 109: 267–281.

142
Merck Index. 1996. The Merck Index, Merck & Co., Inc., Whitehouse Station, N.J.
Milani, N. 2001. Activity of oxalic acid and citric acids on the mite Varroa destructor in
laboratory assays. Apidologie 32(2): 127-138.
Milani, N. and M. Iob. 1998. Plastic strips containing organophosphorous acaricides to
control Varroa jacobsoni: a preliminary experiment. American Bee Journal 138(8):
612-615.
Milani, N. 1994. Possible presence of fluvalinate-resistant strains of Varroa jacobsoni in
northern Italy. In A. Matheson [ed.], New perspectives on Varroa. IBRA, Cardiff,
UK. p. 87.
Nanetti, A., R. Büchler, J.D. Charrière, I. Fries, S. Helland, A. Imdorf, S. Korpela, and P.
Kristiansen. 2003. Oxalic acid treatments for Varroa control (Review). Apiacta 38:
81-87.
National Agricultural Statistics Service (NASS). 1993. A look at the U.S. beekeeping
industry (http://gears.tucson.ars.ag.gov/dept/abf.html). Accessed September 10, 2007.
Nauen, R. and T. Bretschneider. 2002. New modes of action of insecticides. Pesticide
Outlook 13: 241-245.
Peng, Y.S., Y. Fang, S. Xu, and L. Ge. 1987. The resistance mechanism of the Asian
honey bee, Apis cerana Fabr., to an ectoparasitic mite, Varroa jacobsoni Oudemans.
Journal of Invertebrate Pathology 49(1): 54-60.
Pettis, J.S. 2004. A scientific note on Varroa destructor resistance to coumaphos in the
United States. Apidologie 35: 91-92.
Pettis, J.S., H. Shimanuki, and M.F. Feldlaufer. 1998. An assay to detect fluvalinate
resistance in Varroa mites. American Bee Journal 138(7): 538-541.
Plapp, F. W., and S. B. Vinson. 1977. Comparative toxicities of some insecticides to the
tobacco budworm and its ichneumonid parasite (Campoletis sonorensis).
Environmental Entomology 6(3): 381-384.
Popov, E.T., V.N. Melnik, and A.N. Matchinev. 1989. Application of oxalic acid in
varroatosis. Proc. XXXII Int. Congr. Apimondia, Rio de Janeiro, Apimondia Publ.
House, Bucharest, p. 149.
Rademacher, E., and M. Harz. 2006. Oxalic acid for the control of varroosis in honey bee
colonies-a review. Apidologie 37: 98-120.
Rademacher, E., and A. Imdorf. 2004. Legalization of the use of oxalic acid in varroa
control. Bee World 85(4): 70-72.

143

Ramirez, B.W. 1994. Conformation of the ambulacrum of Varroa jacobsoni Oud. and
mite control with dusts. American Bee Journal 134(12): 835.
Ramirez, B.W., and G.J. Malavasi. 1991. Conformation of the ambulacrum of Varroa
jacobsoni Oudemans (Mesostigmata: Varroidae): a grasping structure. International
Journal of Acarology 17(3): 169-173.
Rehm, S.M., and W. Ritter. 1989. Sequence of the sexes in the offspring of Varroa
jacobsoni and the resulting consequences for the calculation of the developmental
period. Apidologie 20(4): 339-343.
Ruijter, A.D., and N. Pappas. 1983. Karyotype and sex determination of Varroa
jacobsoni Oud. In R. Cavalloro [ed.], Varroa jacobsoni Oud. affecting honey bees:
present status and needs. A.A. Balkema / Rotterdam, Netherlands. pp. 41-44.
Sammataro, D. 1997. Report on parasitic honey bee mites and disease associations.
American Bee Journal 137(4): 301-302.
Sanford, M.T. 2001. Introduction, spread, and economic impact of Varroa mites in North
America. In K.S. Delaplane and T.C. Webster [ed.] Mites of the Honey Bees. Dadant
& Sons, Inc., Hamilton, Illinois. pp. 149-162.
SAS Institute. 2006. SAS/STAT user’s guide, version 9.1. SAS Institute; Cary, NC,
USA.
Schuster, H., and F. Schürzinger. 2003. Oxalsäure zur Sommerbehandlung? Allg. Dtsch.
Imkerztg. 1: 27-28.
Shah, F.A., and T.A. Shah. 1988. Tropilaelaps clareae, a serious pest of honey bees;
flour dusting controls for Varroa disease. American Bee Journal 128(1): 27.
Sheppard, W.S., M. Gardner, S. Hasher, B. Kahkonen, M.D. Meixner, and J.P. Strange.
2003. Use of sucrose octanoate esters to control the parasitic honey bee mite Varroa
destructor. American Bee Journal 143(12): 982-985.
Shimanuki, H., N.W. Calderone, and D.A. Knox. 1994. Parasitic mite syndrome: the
symptoms. American Bee Journal 134(12): 827-828.
Shimanuki, H., and D.A. Knox. 2000. Diagnosis of honey bee diseases. U.S. Department
of Agriculture, Agricultural handbook No. AH-690. 61p.
Singh, P.P., L.K. Kothari, D.C. Sharma, and S.N. Saxena. 1972. Nutritional value of
foods in relation to their oxalic acid content. The American Journal of Clinical
Nutrition 25: 1147-1152.

144
Special supplement. 2005. Conditions of use for: oxalic acid dihydrate for control of
varroa mites in honey bee colonies. Hivelights 18(4).
Spivak, M., and G.S. Reuter. 2001. Varroa destructor infestation in untreated honey bee
(Hymenoptera: Apidae) colonies selected for hygienic behavior. Journal of Economic
Entomology 94(2): 327-331.
Strange, J.P., and W.S. Sheppard. 2001. Optimum timing of miticide applications for
control of Varroa destructor (Acari: Varroidae) in Apis mellifera (Hymenoptera:
Apidae) in Washington State, USA. Journal of Economic Entomology 94(6): 13241331.
Tabor, K.L., and J.T. Ambrose. 2001. The use of heat treatment for control of the honey
bee mite, Varroa destructor. American Bee Journal 141(10): 733-736.
Thompson, H.M., M.A. Brown, R.F. Ball, and M.H. Bew. 2002. First report of Varroa
destructor resistance to pyrethroids in the UK. Apidologie 33: 357-366.
USDA, 2007. National agricultural statistics service. Honey
(http://usda.mannlib.cornell.edu/MannUsda/viewDocumentInfo.do?documentID=119
1). Accessed September 10, 2007.
U.S. EPA. 2007a. U.S. Environmental Protection Agency. Pesticides
(http://www.epa.gov/oppsrrd1/REDs/taufluvalinate_red.pdf). Accessed September
11, 2007.
U.S. EPA. 2007b. U.S. Environmental Protection Agency. Pesticides
(http://www.epa.gov/fedrgstr/EPA-PEST/2007/May/Day-09/p8954.htm). Accessed
September 11, 2007.
U.S. EPA. 2006a. Sucrose Octanoate Esters (PC Code 035300). U.S. Environmental
Protection Agency Office of Pesticide Programs Biopesticides and Pollution
Prevention Division
(http://www.epa.gov/pesticides/biopesticides/ingredients/factsheets/factsheet_035300
.htm). Accessed September 11, 2007.
U.S. EPA. 2006b. U.S. Environmental Protection Agency. Pesticides
(http://www.epa.gov/pesticides/biopesticides/ingredients/factsheets/factsheet_080402
.htm). Accessed September 12, 2007.
U.S. EPA. 2005. U.S. Environmental Protection Agency. Pesticides
(http://www.epa.gov/pesticides/biopesticides/ingredients/factsheets/factsheet_214900
.htm). Accessed September 12, 2007.

145
van Buren N.W.M., Mariën A.G.H., and Velthuis H.H.W. 1992. The role of trophallaxis
in the distribution of Perizin in a honeybee colony with regard to the control of the
Varroa mite. Entomol. exp. appl. 65: 157-164.

